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DNA nanotechnology has been enormously successful in using DNA as a nanoscale 
construction material, and consistent progress in using increasingly complex DNA-
mediated assemblies and designs has been reported in the literature. However, the field 
of DNA nanostructures has sometimes been lacking for concrete applications. 
Meanwhile, DNA has also been widely used as probes and primers for nucleic acid 
diagnostics applications, and this provides an extremely critical application with 
potential for great medical benefits, and these DNA probes and primers are readily 
interfaced with DNA nanotechnology. Thus, in this Dissertation, I discuss the 
combination of (1) DNA in its role as a recognition element for nucleic acid detection, and 
(2) DNA as a structural material for nanoscale self-assembly. This combination represents 
a fusion of “structure” and “function”, and will ultimately lead to great advancements in 
the field of nucleic acid diagnostics. 
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CHAPTER 1 
INTRODUCTION 
 
In this dissertation, I will utilize DNA nanostructures in molecular diagnostics to 
demonstrate how the unique advantages of DNA nanostructures, including 
multifunctionality and precise controllability, can be leveraged for nucleic acid 
detection applications. In this introduction, I will discuss how the structural 
properties of DNA have enabled the development of progressively more 
complex DNA nanostructures. Next, I will explore how the biological importance 
of nucleic acids has led to the burgeoning field of molecular diagnostics for 
research and clinical applications. Finally I will outline how the integration of 
DNA nanostructures can lead to significant improvements for existing molecular 
diagnostic techniques. 
 
1.1 DNA nanostructures 
In recent decades, DNA has gained attention as an excellent structural material 
for nanometer-scale engineering. As illustrated in Table 1.1, DNA has several 
unique properties that motivate its use for engineering nanostructures.  
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Ease of handling 
• Facile synthesis 
• Chemical stability 
• Simple modification 
Biological significance 
• DNA-processing enzymes 
• Important applications in 
delivery and diagnostics 
Predictable behavior 
• Watson-Crick base pairing 
• in silico modeling 
Table 1.1: Summary of DNA’s attributes, which make it attractive as a material 
for structural engineering at the nanometer scale. 
 
Firstly, DNA is easy and convenient both to synthesize and to handle in the 
laboratory. Single-stranded DNA oligonucleotides can be synthesized 
commercially at low cost with reliable yield and purity. The chemical structure of 
DNA is consistent and well-controlled; in particular, in double-stranded DNA 
the position of any specific base placement is effectively controlled with a 
resolution of approximately 0.34 nanometers. Additionally, with appropriate 
handling DNA is extraordinarily stable, especially when lyophilized (e.g. as 
demonstrated by the genetic analysis of ancient mummified human remains). 
This stability reflects its natural role as the primary biological information 
storage medium. Conditions in the laboratory can be controlled to prevent DNA 
degradation or spontaneous mutation as a result of oxidative damage or 
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radiation. Furthermore, a variety of chemical and bio-functional modifications, 
such as fluorescent labels, quenchers, biotin for further functionalization, and 
chemical groups, can be appended to synthetic DNA oligonucleotides. These 
moieties may enable specific functions as well as further modification.  
Secondly, DNA has substantial biological significance. The vital role of DNA in 
fundamental biological processes has resulted in the co-evolution of a wide 
variety of DNA-associated enzymes that can manipulate and process. The 
possibility of enzymatic processing further expands the versatility and 
controllability of DNA as an engineering material. The biological relevance of 
DNA has also led to important applications such as molecular diagnostics (the 
focus of this dissertation). It must be noted that this biological significance is not 
entirely unique to DNA, but is also true of other biopolymers including proteins 
and carbohydrates. 
The third important property of DNA, which motivates its use in nanostructural 
engineering and distinguishes it from the other biopolymers, is its predictability. 
DNA follows Watson Crick base-pairing rules. DNA forms secondary structures 
that are complex but can frequently be modeled in silico.[1] In contrast, structural 
prediction of proteins or carbohydrates is more complicated, and thus 
engineering nanostructures with these materials has been prohibitively difficult. 
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The predictability of DNA has allowed for a large variety of diverse structures to 
be designed and engineered with confidence, and a number of software packages 
have been extraordinary successful in this regard. 
 
The DNA branched junction 
The basis for engineering DNA nanostructures is the DNA branched junction. 
DNA is typically known to form linear and circular structures; however, it can 
also form branches. This was first understood with studies of genetic 
recombination, where the four-armed X-shaped DNA branch became known as 
the Holliday junction after Robin Holliday, who proposed it in 1964.[2] Soon 
additional types of branched DNA structures became known. Seeman and 
coworkers pioneered the first stable, synthetic branched DNA nanostructures by 
designing partially-complementary oligonucleotides that could form various 
junctions such as X-shaped and Y-shaped branched DNA[3–5] and more 
complex shapes such as a cube[6] and an octahedron[7]. This work also led to 
development of double-crossover DNA (discussed in next section of this 
thesis).[8]  
In 2003, Luo laboratory published work on dendrimer-like DNA, which used 
branched structures as basic building blocks, and combined these building 
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blocks into more complex structures via enzymatic ligation (taking advantage of 
DNA-processing enzymes).[9] This work was further developed through the 
production of an enzyme-catalyzed DNA hydrogel,[10] DNA nanobarcodes,[11], 
[12] and ABC monomers,[13] leading to applications in detection and cell-free 
protein production[14], [15]. Meanwhile other workers have utilized branched 
DNA to generate bulk scale DNA hydrogels and dendrimers based entirely on 
DNA hybridization without the use of enzymes [16], [17].  
 
Double crossover DNA 
As work continued on simple branched DNA nanostructures, other workers 
focused on slightly more complex basic structures for DNA building blocks: 
double crossover DNA. The basic design for double crossover DNA was first 
popularized by Seeman.[18] Later works showed its usage in complex tiling and 
patterned structures, which led to a large number of impressive 
demonstrations.[19] Importantly, the use of double crossover DNA allows for 
DNA nanostructures that are rigid and well-defined, in contrast to simple 
branched DNA nanostructures that are relatively flexible. 
The DNA crossover design was used as the underlying scaffold for DNA 
origami, which utilized very long single-stranded DNA (the template strand, 
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such as M13 phage DNA) that was linked together into a pre-defined structure 
using a large number of shorter single-stranded DNA (“staple strands”).[20] 
DNA origami has allowed an unprecedented level of control over custom DNA 
nanostructures and has become an extremely popular approach for design and 
construction of a large variety of synthetic DNA nanostructures. More recently, 
this strategy has also been used in a “molecular canvas” approach, which is 
similar to DNA origami but utilizes many short strands of DNA without any 
long single-stranded template strand.[21] 
 
1.2 Molecular diagnostics 
Nucleic acids are extremely important biomarkers and can be useful indicators of 
disease. Pathogens carry genetic information that can be specifically recognized 
and identified as foreign relative to the healthy disease-free organism. Expressed 
messenger RNA (mRNA) can be profiled to give information about the current 
state of the organism, tissue, or cell, and thus provides a “bird’s eye view” of the 
functioning of a biological system. The genetic code can be considered as the 
original source for information transmission in the organism, and thus can be 
useful for clinical prognostics and for the diagnosis of non-infectious diseases 
such as autoimmune diseases or cancer. 
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The biological importance of nucleic acids, as the “information medium of life”, 
has led to the growth and development of the molecular diagnostics field. 
Historically, protein/antibody-based diagnostics were the most popular basis for 
in vitro disease detection. However, as of this writing in 2013, nucleic acid-based 
diagnostics are growing in importance largely due to the high expectations 
raised by next generation sequencing. Nucleic acid-based detection has crucial 
advantages relative to immunologically-based tests: its compatibility with 
exponential enzymatic amplification, its simplicity and predictability (DNA 
primers and probes can be synthesized quickly and easily whereas new 
antibodies must be raised through a longer process), and its ability to distinguish 
specific genetic markers that may be difficult or impossible to detect through 
immunological means. As a result of exponential enzymatic amplification, 
sensitivity of nucleic-acid based tests is generally higher than immunologically 
based tests – PCR can technically amplify even a single molecule of target DNA 
or RNA in a pathogenic sample. As a result of this higher sensitivity, PCR-based 
assays are a popular approach for certain clinical scenarios (e.g. viral load testing 
for HIV). 
In this introduction, “molecular diagnostics” is defined to encompass at least 
three broad methods, each of great significant for clinical medicine: nucleic acid 
tests (enzymatic amplification including PCR and isothermal amplification 
7 
 
techniques), gene expression profiling (DNA microarrays), and DNA 
sequencing. 
 
Nucleic acid tests for detection 
Currently almost all molecular diagnostics make use of PCR. PCR takes 
advantage of the natural genetic replication of DNA for in vitro amplification. 
Traditionally, PCR utilizes a thermostable DNA polymerase enzyme (such as 
Taq) and thermal cycling to carry out multiple rounds of successive 
denaturation, annealing, and extension. Successful amplification requires 
primers that are specifically designed to bind to a template strand (which may 
also be referred to as the target strand). During the PCR process, every cycle 
yields a two-fold increase in the amount of product nucleic acid, resulting in 
exponential amplification. Theoretically, this amplification takes place only in the 
presence of the template strand. Thus, the “output” of the PCR is a large amount 
of a specific DNA product, which is traditionally characterized using gel 
electrophoresis. 
Upon its development, PCR rapidly became of great importance in almost all 
areas of molecular biology, and was very popular and useful for detection 
applications. However, traditional PCR is unsuitable for accurate quantitative 
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measurements of target DNA in an unknown sample, because large amounts of 
DNA product are generated whether the original amount of target DNA is large 
or small. This issue was resolved by the development of quantitative PCR 
(qPCR). In a typical qPCR process, the amount of product is monitored as it 
occurs in real time, through the use of a DNA-specific dye, molecular beacon, or 
similar technique. Considering the number of cycles required to achieve a certain 
amount of PCR product, and the amplification rate of the PCR process, qPCR 
results in a more accurate estimate of the original amount of DNA template. 
Thus qPCR can be extremely valuable for making diagnoses when quantitative, 
rather than qualitative, results are beneficial or necessary. 
Aside from the lack of quantitative information, another disadvantage of 
traditional PCR is the time and equipment (and associated electrical energy 
requirement) needed for thermal cycling. The requirement for thermal cycling 
can be avoided through the use of isothermal amplification techniques. Many 
different enzyme-based isothermal amplification techniques are possible, 
including rolling circle amplification (RCA), loop mediated amplification 
(LAMP), helicase-dependent amplification (HDA), and nucleic acid based 
sequence amplification (NASBA), as well as many others. These technologies are 
functionally similar to PCR, using enzymes to amplify the template or target 
DNA strand. Typically, these isothermal amplification techniques are more 
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complex than PCR, requiring additional enzymes or primers, and relatively 
complicated primer design. (In effect, the “procedural complexity” represented 
by thermal cycling is exchanged for “chemical complexity” in terms of the 
components of the reaction.) Currently, PCR remains the “gold standard” for 
nucleic acid testing, too widely-used and well-understood to be replaced by any 
isothermal technique, except in niche applications such as point-of-care 
diagnostics. 
 
Gene expression profiling 
The broad goal of gene expression profiling is to identify and quantify the 
activity of many genes (on the order of thousands) that are being expressed by a 
given organism, tissue, or cell. A typical expression profiling experiment may 
utilize enzymatic amplification as part of the process. The traditional approach to 
carry out gene expression experiments is using hybridization-based DNA 
microarrays. In this approach, single-stranded “capture probe” oligonucleotides 
are attached to a solid support. Each capture probe hybridizes to a specific 
nucleic acid that may be present in the test sample, and this hybridization event 
triggers a specific measureable response. By assessing the amount of each type of 
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mRNA present in the sample, a global picture of cellular function can be 
obtained. 
DNA microarrays are the traditional tool for gene expression profiling, but many 
alternative formats are possible. The Nanostring© platform has gained attention 
as a successful method to profile individual mRNA molecules using fluorescence 
microscopy.[22] In addition, as next generation sequencing has grown in 
popularity, sequencing-based methods for gene expression profiling have 
emerged as an alternative to more DNA microarray-based approaches. These 
sequencing-based expression profiling methods may be referred to as RNA-Seq 
or transcriptome sequencing. 
 
DNA sequencing 
Next generation sequencing (NGS) has proved extremely useful and is currently 
growing in importance for both research and clinical applications.[23] For a 
typical NGS experiment, the target nucleic acid is fragmented and amplified to 
form identical copies of different fragments. Each fragment is sequenced in 
parallel with data being collected from all sequencing reactions simultaneously. 
The sequencing data collected from each fragment is aligned and assembled 
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together, either using an existing known sequence as a scaffold (re-sequencing) 
or without any pre-existing information (de novo sequencing).  
The increasing prominence of next generation sequencing has important 
implications for personalized medicine. As the cost and time required for 
sequencing is reduced, it is becoming increasingly practical to sequence the 
genome for every individual patient to obtain predictive information about their 
genetic predisposition to disease and compatibility with specific treatments. In 
the case of cancer, it is desirable to sequence tumor cells to assess the 
susceptibility of a specific tumor for alternative treatments. Thus, NGS is part of 
the new standard of care for cancer, and will certainly play a prominent role in 
the future of healthcare. 
 
1.3 DNA nanostructures for molecular diagnostics 
Traditional molecular diagnostics do not take advantage of DNA nanostructures. 
However, traditional molecular diagnostic methods do require many DNA-
based components (primers and probes). These can be potentially replaced or 
modified with DNA nanostructures such as branched DNA. This is an excellent 
opportunity to introduce novel characteristics, which are attainable by DNA 
nanostructures but not by conventional linear primers and probes, such as 
12 
 
anisotropic multifunctionality and precise controllability, which may introduce 
important capabilities and advantages for detection.  
As one example of branched DNA probes, Um and coworkers developed DNA-
based “fluorescent nanobarcodes” to simultaneously identify multiple pathogen 
DNA sequences [11], [12]. Each nanobarcode encoded a unique identifier, 
something like a common supermarket barcode. In the presence of pathogen 
DNA sequences, these nanobarcodes hybridized to the target DNA and were 
detected by fluorescence microscopy. Based on the fluorescent color ratio of each 
aggregate, the identity of pathogen DNA was easily determined. This strategy 
uses “reaction encoding”, with the pathogen identity contained within the label 
itself, rather than “spatial encoding” as used by conventional DNA microarrays. 
Using multiple types of nanobarcodes, each complementary to a different 
pathogen DNA sequence, many different pathogens could be detected 
simultaneously.  
Another example of branched DNA for sensing is the so-called branched DNA 
(bDNA) assay which uses branched DNA to amplify the signal from a target 
DNA strand. This strategy is similar to the enzyme-linked immunosorbent assay 
(ELISA), in which the signal from a primary antibody is amplified by a multi-
labeled secondary antibody; however, hybridization between complementary 
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DNA sequences replaces the specific antibody-antigen interactions in ELISA. 
After hybridization based-amplification, the resulting branched structures are 
labeled with an enzyme to generate an amplified signal.[24] This approach has 
been successfully commercialized for a number of clinical applications, but its 
popularity is limited relative to established approaches such as PCR. 
 
 
Figure 1.1: Scheme illustrating the combined roles of nucleic acids for detection 
with DNA nanotechnology-enabled structures for the development of novel 
diagnostics. 
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 1.4 Significance of this dissertation 
DNA nanostructures can be directly implemented into existing approaches for 
molecular diagnostics. The key consideration is whether the added benefits of 
DNA nanostructures (multifunctionality and controllability) outweigh the added 
complexities of synthesizing and integrating DNA nanostructures into existing 
strategies. I argue that integrating DNA nanostructures into existing molecular 
diagnostics will have many potential benefits, the added complexity of DNA 
nanostructures is low, and the possibility of implementing DNA nanostructures 
into existing molecular diagnostics is a rich area for exploration and should be 
seriously considered. With the rise of NGS and growing popularity of molecular 
diagnostics, it is increasingly important to thoroughly explore these options. 
In this dissertation I explore two important concepts that are related to the use of 
DNA nanostructures in diagnostic applications. Chapter 2 discusses the stability 
of DNA nanostructures. Despite the great advantages of utilizing DNA 
nanostructures as probes and/or primers, DNA nanostructures have the 
fundamental limitation that they are denatured under harsh conditions. As a 
result, DNA nanostructures typically cannot be used in any applications that 
involve denaturing conditions (high temperatures, low salinity, high pH, and 
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presence of certain chaotropic chemicals), and this limits their real-world 
applications including their use in diagnostics. I have aimed to address this 
limitation in a simple and direct manner by utilizing a chemical cross-linking 
method that creates covalent bonds between double-stranded DNA and results 
in a stabilized (thermostable) structure. This enables DNA nanostructures to be 
used as probes or primers even in high temperature applications such as PCR. 
Chapter 3 discusses the concept of point-of-care nucleic acid detection, including 
an overview of the field and prominent examples from the literature. Chapter 4 
addresses the issue of hybridization kinetics. Surface-based hybridization is 
fundamentally slower than solution phase hybridization, and also requires 
specific functionalization and treatment of surface chemistry to enable desired 
interactions and prevent fouling. I propose the use of solution-based 
hybridization for detection that is more rapid and avoids the requirement of 
surface modification. The significance of this work is discussed in regards to 
point-of-care diagnostics, with specific considerations on applying this work 
toward resource-limited settings such as the developing world. 
 
 
 
16 
 
 1.5 References 
[1] J. SantaLucia and D. Hicks, “The thermodynamics of DNA structural 
motifs.,” Annu Rev Biophys Biomol Struct, vol. 33, pp. 415–40, Jan. 2004. 
[2] Y. Liu and S. C. West, “Happy Hollidays: 40th anniversary of the Holliday 
junction.,” Nat Rev Mol Cell Biol, vol. 5, no. 11, pp. 937–44, Nov. 2004. 
[3] R. I. Ma, N. R. Kallenbach, R. D. Sheardy, M. L. Petrillo, and N. C. Seeman, 
“Three-arm nucleic acid junctions are flexible.,” Nucleic Acids Res, vol. 14, 
no. 24, pp. 9745–53, Dec. 1986. 
[4] N. R. Kallenbach, R.-I. Ma, and N. C. Seeman, “An immobile nucleic acid 
junction constructed from oligonucleotides,” Nature, vol. 305, no. 5937, pp. 
829–831, Oct. 1983. 
[5] N. C. Seeman and N. R. Kallenbach, “Design of immobile nucleic acid 
junctions.,” Biophys J, vol. 44, no. 2, pp. 201–9, Nov. 1983. 
[6] J. H. Chen and N. C. Seeman, “Synthesis from DNA of a molecule with the 
connectivity of a cube.,” Nature, vol. 350, no. 6319, pp. 631–3, Apr. 1991. 
[7] Y. Zhang and N. C. Seeman, “Construction of a DNA-Truncated 
Octahedron,” J Am Chem Soc, vol. 116, no. 5, pp. 1661–1669, Mar. 1994. 
[8] N. C. Seeman, “DNA in a material world.,” Nature, vol. 421, no. 6921, pp. 
427–31, Jan. 2003. 
[9] Y. Li, Y. D. Tseng, S. Y. Kwon, L. D’Espaux, J. S. Bunch, P. L. McEuen, and 
D. Luo, “Controlled assembly of dendrimer-like DNA.,” Nature Materials, 
vol. 3, no. 1, pp. 38–42, Jan. 2004. 
[10] S. H. Um, J. B. Lee, N. Park, S. Y. Kwon, C. C. Umbach, and D. Luo, 
“Enzyme-catalysed assembly of DNA hydrogel.,” Nature Materials, vol. 5, 
no. 10, pp. 797–801, Oct. 2006. 
17 
 
[11] Y. Li, Y. T. H. Cu, and D. Luo, “Multiplexed detection of pathogen DNA 
with DNA-based fluorescence nanobarcodes.,” Nature Biotechnology, vol. 
23, no. 7, pp. 885–9, Jul. 2005. 
[12] S. H. Um, J. B. Lee, S. Y. Kwon, Y. Li, and D. Luo, “Dendrimer-like DNA-
based fluorescence nanobarcodes.,” Nat Protoc, vol. 1, no. 2, pp. 995–1000, 
Jan. 2006. 
[13] J. B. Lee, Y. H. Roh, S. H. Um, H. Funabashi, W. Cheng, J. J. Cha, P. 
Kiatwuthinon, D. A. Muller, and D. Luo, “Multifunctional 
nanoarchitectures from DNA-based ABC monomers.,” Nature 
Nanotechnology, vol. 4, no. 7, pp. 430–6, Jul. 2009. 
[14] N. Park, S. H. Um, H. Funabashi, J. Xu, and D. Luo, “A cell-free protein-
producing gel.,” Nature Materials, vol. 8, no. 5, pp. 432–7, May 2009. 
[15] N. Park, J. S. Kahn, E. J. Rice, M. R. Hartman, H. Funabashi, J. Xu, S. H. 
Um, and D. Luo, “High-yield cell-free protein production from P-gel.,” 
Nature Protocols, vol. 4, no. 12, pp. 1759–70, Jan. 2009. 
[16] Y. Xing, E. Cheng, Y. Yang, P. Chen, T. Zhang, Y. Sun, Z. Yang, and D. Liu, 
“Self-assembled DNA hydrogels with designable thermal and enzymatic 
responsiveness.,” Advanced Materials, vol. 23, no. 9, pp. 1117–21, Mar. 2011. 
[17] T. Zhou, P. Chen, L. Niu, J. Jin, D. Liang, Z. Li, Z. Yang, and D. Liu, “pH-
responsive size-tunable self-assembled DNA dendrimers.,” Angew Chem 
Int Ed Engl, vol. 51, no. 45, pp. 11271–4, Nov. 2012. 
[18] X. Li, X. Yang, J. Qi, and N. C. Seeman, “Antiparallel DNA Double 
Crossover Molecules As Components for Nanoconstruction,” J Am Chem 
Soc, vol. 118, no. 26, pp. 6131–6140, Jan. 1996. 
[19] E. Winfree, F. Liu, L. A. Wenzler, and N. C. Seeman, “Design and self-
assembly of two-dimensional DNA crystals.,” Nature, vol. 394, no. 6693, 
pp. 539–44, Aug. 1998. 
[20] P. W. K. Rothemund, “Folding DNA to create nanoscale shapes and 
patterns.,” Nature, vol. 440, no. 7082, pp. 297–302, Mar. 2006. 
[21] B. Wei, M. Dai, and P. Yin, “Complex shapes self-assembled from single-
stranded DNA tiles.,” Nature, vol. 485, no. 7400, pp. 623–6, May 2012. 
18 
 
[22] G. K. Geiss, R. E. Bumgarner, B. Birditt, T. Dahl, N. Dowidar, D. L. 
Dunaway, H. P. Fell, S. Ferree, R. D. George, T. Grogan, J. J. James, M. 
Maysuria, J. D. Mitton, P. Oliveri, J. L. Osborn, T. Peng, A. L. Ratcliffe, P. J. 
Webster, E. H. Davidson, L. Hood, and K. Dimitrov, “Direct multiplexed 
measurement of gene expression with color-coded probe pairs.,” Nat 
Biotechnol, vol. 26, no. 3, pp. 317–25, Mar. 2008. 
[23] A. S. Gargis, L. Kalman, M. W. Berry, D. P. Bick, D. P. Dimmock, T. 
Hambuch, F. Lu, E. Lyon, K. V Voelkerding, B. A. Zehnbauer, R. Agarwala, 
S. F. Bennett, B. Chen, E. L. H. Chin, J. G. Compton, S. Das, D. H. Farkas, 
M. J. Ferber, B. H. Funke, M. R. Furtado, L. M. Ganova-Raeva, U. 
Geigenmüller, S. J. Gunselman, M. R. Hegde, P. L. F. Johnson, A. Kasarskis, 
S. Kulkarni, T. Lenk, C. S. J. Liu, M. Manion, T. A. Manolio, E. R. Mardis, J. 
D. Merker, M. S. Rajeevan, M. G. Reese, H. L. Rehm, B. B. Simen, J. M. 
Yeakley, J. M. Zook, and I. M. Lubin, “Assuring the quality of next-
generation sequencing in clinical laboratory practice.,” Nat Biotechnol, vol. 
30, no. 11, pp. 1033–6, Nov. 2012. 
[24] A. N. Player, L.-P. Shen, D. Kenny, V. P. Antao, and J. A. Kolberg, “Single-
copy Gene Detection Using Branched DNA (bDNA) In Situ 
Hybridization,” Journal of Histochemistry & Cytochemistry, vol. 49, no. 5, pp. 
603–611, May 2001.  
 
19 
 
CHAPTER 2 
BRANCHED PCR USING THERMOSTABLE DNA NANOSTRUCTURES AS 
MODULAR PRIMERS 
 
2.1 Introduction 
The extraordinary controllability of synthetic DNA nanostructures offers great 
potential for nanotechnology and biotechnology,[1–5] with applications 
including self-assembly,[6–11] sensing,[12–15] and DNA-based materials.[16–19] 
However, DNA nanostructures are unstable at high temperatures due to the 
inherent thermal instability of base pairing, which limits their real-world 
applications. Recent work has demonstrated the use of psoralen, a naturally-
occurring reagent that intercalates and cross-links DNA,[20] to create DNA 
origami structures with enhanced thermal stability.[21], [22] In addition, other 
thermostable bonds have been introduced in the form of DNA-organic molecule 
hybrids to construct DNA structures and networks.[23–25] 
In this Chapter, I present a general approach using our previously-reported 
branched DNA building blocks[26], [27] combined with psoralen cross-linking to 
produce thermostable branched DNA nanostructures. These thermostable 
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branched DNA nanostructures can withstand denaturing conditions without 
disruption of their integrity. Importantly, this system is extremely modular. 
Simple nanostructures can be combined in a controlled fashion (via enzymatic 
ligation) to form increasingly complex nanostructures, and individual 
component oligonuleotides can be “swapped out” for different labelling and 
functions.  
This unique modularity enabled us to utilize thermostable branched DNA 
nanostructures as modular primers in polymerase chain reaction (PCR), 
achieving novel “branched PCR.” Our branched PCR maintains the 
controllability of branched DNA nanostructures, while preserving the biological 
function of the resulting PCR products. Furthermore, we demonstrate the 
novelty and utility of branched PCR through the realization of multifunctional 
labelling for detection, synthesis of branched PCR products, and hydrogel 
formation, none of which can be achieved by conventional PCR. 
 
2.2 Approach 
Our branched thermostable DNA structures were formed by a two-step process, 
as shown in Figure 2.1. In the first step, we synthesized Y-shaped DNA following 
our previously-reported protocol.[26] Briefly, three single-stranded DNA were 
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rationally designed with specific sequences such that each was partially 
complementary to another, resulting in self-annealed, branched, Y-shaped DNA. 
In the second step, the structures were incubated with psoralen and briefly 
exposed to UV illumination. DNA sequences were deliberately designed to yield 
a high proportion of interstrand cross-linking sites during this psoralen 
treatment step (Figure 2.2). Sequences are shown in Table 2.1. 
 
 
Figure 2.1: Illustration of cross-linking of branched DNA structures. Single-
stranded oligonucleotides hybridize to form branched DNA nanostructures 
through DNA base-pairing. Resulting nanostructures are treated with psoralen 
to cause covalent interstrand cross-linking. Resulting structures are thermostable 
and will remain intact under denaturing conditions.  
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Figure 2.2: Diagram of sequences for Y-shaped and X-shaped DNA branches 
used in this work. Arrows indicate 5’ to 3’ polarity. Psoralen cross-linking is most 
likely to occur at 5’-TA-3’ and 5’-AT-3’ sites, which are indicated with red text. 
Varying the number of 5’-TA-3’ and 5’-AT-3’ sites changes the effective yield of 
cross-linked “thermostable” product. 
 
After this simple treatment, the branched DNA nanostructures were 
thermostable and remained intact even under denaturing conditions. These 
thermostable branched DNA nanostructures were ideal for high temperature-
based applications, such as PCR. To implement our structures in PCR, we simply 
substituted our modular primers in place of the standard linear primers, as 
shown in Figure 2.3. During the denaturing phase of PCR, the linear template 
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was denatured while the modular primers remained intact due to the cross-
linking with psoralen. During the annealing and extension phases, the modular 
primers hybridized to the template and were extended by the polymerase, 
resulting in a “dumbbell-shaped” product. Exponential amplification occurred as 
usual, except that products were branched. 
 
 
Figure 2.3: Illustration of cross-linked branched DNA structures for use in PCR. 
Cross-linked products can be used in PCR as modular primers, replacing the 
conventional linear primers, resulting in branched PCR products. 
 
 
2.3 Experimental methods 
Preparation of DNA nanostructures. Oligonucleotides were ordered from 
Integrated DNA Technologies (IDT) with sequences as shown below. Branched 
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Y-shaped and X-shaped DNA structures were prepared according to previously 
published methods from our group.[26] Briefly, branched DNA structures were 
synthesized by mixing the same molar amount of corresponding oligonucleotide 
strands. To form fluorescent tagged Y-shaped DNA, commercially synthesized 
fluorescent tagged oligonucleotide strands were used. 
 
Oligonucleotide sequences. For experiments with modular primers, the primer 
sequences shown in Table 2.1 were appended directly to the 3' end of the desired 
core sequences. For experiments involving ligation, the single-stranded overhang 
sequences shown in Table 2.1 were added directly to the 5' end of the desired 
core sequences. For experiments with fluorescent Y-shaped DNA, FAM (green) 
or Cy5 (red) modifications were added directly to the 5' end of the desired core 
sequences. 
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 Core sequences  
Used for preparing the building blocks for DNA nanostructures 
Y-shaped DNA sequences 
Y1 TGGACCGATATCATATGTACATTACTATAGTACCTGAG 
Y2 CTCAGGTACTATAGTAATGATCATCTATAGTACAGCCT 
Y3 AGGCTGTACTATAGATGATTACATATGATATCGGTCCA 
X-shaped DNA sequences 
X1 ACCGACCGATATGGTATACGGT 
 
X2 CAGCGGTATAGGTACGGATCTG 
 
X3 AGACGATGCGATCGCTACTACG 
 
X4 CTCGCGGTACCTACGTACTAGC 
 Functional sequences 
Used for introducing enzymatic function to DNA nanostructures 
Primer sequences (append to 3' end of core sequences) 
Primer1a 
 
AGCGTGGACACGAGTCC 
Primer1b 
 
CCAATCTTGTCACCTCTGAC 
Primer2a 
 
TGGATCCGACCGACCGATATGG 
Primer2b 
 
GAGGCTGTCTCGCGGTACC 
Primer3a 
 
ACCACAGTCCATGCCATCAC 
Primer3b 
 
TCCACCACCCTGTTGCTGTA 
Single-stranded overhang sequences for ligation (append to 5' end of core 
sequences) 
ssOverhang1a /5Phos/GCAA 
ssOverhang1b /5Phos/TTGC 
ssOverhang2a /5Phos/ATCC 
ssOverhang2b /5Phos/GGAT 
Table 2.1: Sequences used for assembly of branched DNA structures. All 
sequences given in the 5' to 3' direction. 
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Chemical cross-linking of DNA nanostructures. Samples were cross-linked by 
mixing with psoralen (trioxsalen, Sigma Aldrich) at a 1:1 molar ratio between 
psoralen and DNA base pair, diluted in 50 mM NaCl in TE buffer to total volume 
of 500 µL and transferred to 24-well plate for cross-linking. Photo irradiation was 
performed using XL-1000 UV Crosslinker (Spectrolinker). Samples were exposed 
to 365 nm UV-A illumination at 2.5 mW/cm2 for 15 minutes at room temperature. 
The thermostable property was confirmed with 15% Ready Gel TBE-urea 
polyacrylamide denaturing gel (BioRad). Samples were run at 150 V for 45 
minutes at room temperature before post-staining with GelRed (Bioneer). 
 
Branched PCR. All PCR reactions were carried out using 2x Taq Master Mix 
(New England Biolabs). PCR was carried out with branched thermostable 
structures replacing the standard linear primers. In a typical PCR experiment, 0.5 
µM of each primer was used with 100 pg of the corresponding target. PCR 
products were confirmed with gel electrophoresis. 
 
AFM imaging. PCR products were diluted in 1X TE Buffer with 2.5-10 mM 
magnesium chloride and deposited onto freshly cleaved mica (TED PELLA) for 
90 seconds. Samples were then rinsed with deionized water and dried with 
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nitrogen.  AFM imaging experiments were performed in air using a MultiMode 8 
AFM (Bruker AXSCorporation, Santa Barbara, CA). Si tips SCANASYST-AIR 
(Bruker AXSCorporation, Santa Barbara, CA) with resonant frequency 45-95 
kHz, spring constant 0.2-0.8 N/m, length 100-130 µm, width 20-30 µm, and tip 
radius < 12 nm were used in the experiments. The samples were scanned in Peak 
Force Tapping mode (PeakForce-Quantitative NanoMechanics, PF-QNM) at 
frequency 2 kHz and Z travel distance 50 nm. The AFM topography images were 
post-processed with Gwyddion 2.30 software. The areas containing the DNA 
structures were masked during post-processing to prevent any changed to the 
DNA contour data. The image background was flattened and leveled. Regular 
noise was removed with 2D FFT filtering. Areas outside the DNA contour were 
processed using conservative denoise and Gaussian blurring filter tools. 
 
Preparation of PCR-generated hydrogel. Following PCR, products were 
concentrated using 10,000 MWCO spin filters (VWR). Resulting viscous solution 
was incubated at 95°C and annealed by gradual cooling from 95°C to 20°C over a 
duration of several hours. The resulting DNA hydrogel was stained with 
GelGreen dye (Bioneer) and photographed under UV illumination. 
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2.4 Results 
Prior to carrying out PCR, we first confirmed the thermal stability of the cross-
linked branch by melting curve analysis. As shown in Figure 2.4, the non-cross-
linked branch exhibited a melting transition at the normal Tm of 55 °C. However, 
no melting transition was evident for cross-linked branches up to 95 °C, although 
absorbance increased slightly at high temperatures due to increased breathing 
within non-cross-linked regions of the double-stranded DNA. In addition, we 
further tested the stability of the cross-linked branch in the presence of a strong 
denaturant (7 M urea) in denaturing gel electrophoresis. The cross-linked branch 
remained intact (Figure 2.5, upper arrow), while the non-cross-linked branch was 
completely denatured into its constituent single-stranded DNA (Figure 2.5, lower 
arrows). 
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Figure 2.4: Melting curve of cross-linked branched DNA (red), and non-cross-
linked branched DNA (green). Absorbance shows clear melting transition only 
for the non-cross-linked sample. 
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Figure 2.5: Denaturing gel electrophoresis of cross-linked branched DNA (red 
arrow), and non-cross-linked branched DNA (green arrows). 
 
To further test the stability of more complex DNA nanostructures using our 
approach, we ligated simple Y- and X-shaped DNA together to form a variety of 
branched DNA nanostructures. Denaturing gel electrophoresis confirmed the 
stability of all nanostructures (Figure 2.6). We also tested the thermal stability of 
complex branched DNA nanostructures during thermal cycling (Figure 2.7). 
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Figure 2.6: Denaturing gel electrophoresis of cross-linked branched DNA. 
Psoralen cross-linking can be combined with the use of DNA “building blocks” 
to construct a wide variety of branched DNA nanostructures. a) Illustration of 
modular approach to construct thermostable DNA nanostructures. After 
formation of Y- or X-shaped DNA “building blocks”, these DNA branches are 
connected via DNA ligase into more complex structures. Following ligation, 
psoralen cross-linking may be carried out to produce thermostable DNA 
nanostructures. b) Denaturing gel electrophoresis of DNA nanostructures. Cross-
linked nanostructures remained intact and ran at high molecular weight 
positions within the denaturing gel. In contrast, non-cross-linked nanostructures 
were denatured during electrophoresis. 
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Figure 2.7: Stability of cross-linked DNA structures against thermocycling. a) 
Formation of three DNA nanostructures. Each DNA nanostructure had a specific 
size and was labelled with a specific color ratio of fluorophores. b) Equimolar 
mixtures of all three branched nanostructures. After thermal cycling (30 rounds 
of 95°C for 30 seconds, 55°C for 30 seconds, 68°C for 30 seconds), cross-linked 
DNA nanostructures each maintained the original color ratio, while non-cross-
linked DNA nanostructures exhibited semi-random scrambling of the color ratio. 
This indicates that the cross-linking enabled nanostructures to be maintained 
even during thermal cycling. c) Schematic illustration of the behavior of DNA 
nanostructures during thermal cycling. 
 
After confirming the stability of the cross-linked branched DNA, we carried out 
PCR replacing the conventional linear primers entirely with our modular 
primers. Obvious branched PCR products were observed in these samples, 
which confirmed that the PCR was successful and indicated that the 
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thermostable treatment did not interfere with the polymerase activity (Figure 2.8). 
We also designed more complex modular primers, which showed similar 
compatibility with PCR (Figure 2.9). These results demonstrated the versatility of 
our modular primer system, which affords the flexibility to realize a variety of 
branched PCR processes. 
 
 
 
 
1       2       3       4       5       6
 
Figure 2.8: Non-denaturing gel electrophoresis of PCR products resulting from 
modular primers. Lane 1: Y-shaped modular primer. Lane 2: PCR product using 
conventional linear primers. Lane 3: PCR product using Y-shaped modular 
primers, resulting in branched DNA product. Lane 4: PCR product using non-
cross-linked branched DNA. Branched DNA is denatured during thermal cycling, 
resulting in non-branched products. Lane 5: PCR product, in which only the 
forward linear primer was replaced with a modular primer. Lane 6: PCR product, 
in which only the reverse linear primer was replaced with a modular primer. 
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Figure 2.9: Multi-branched PCR primers. a) Modular primers were formed from 
two Y-shaped DNA (bottom) and three Y-shaped DNA (top) ligated together. b) 
Gel electrophoresis of PCR products using these modular primers. 
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In conventional PCR, each primer can be labeled with only one fluorophore or 
functional moiety. In contrast, our modular primers can be labeled with multiple 
moieties in a controllable fashion, taking advantage of the anisotropicity of 
branched DNA nanostructures. In our previous work, we developed a “DNA 
nanobarcode” system, which used branched DNA with specific color ratios of 
fluorophores to correspond to specific pathogen targets.[28] Using modular 
primers in conjunction with the DNA nanobarcode concept, we carried out 
multiplexed PCR with three different target DNA sequences, as shown in Figure 
2.10. In the multiplexed PCR, each PCR product was labeled with a specific color 
ratio. This approach enables the simultaneous amplification and labeling of 
target sequences in a single step. 
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Figure 2.10: Gel electrophoresis demonstrating multiplexed PCR using 
multifunctional modular primers. Lanes 1-3: Three modular primers individually, 
showing the specific color ratio for each primer. Lanes 4-6: PCR reactions 
containing all primers yield PCR product with specific color ratio attached to the 
corresponding product. 
 
Conventional linear primers allow polymerization to extend in only one 
direction, resulting in a linear product. The use of modular primers enabled 
polymerization in multiple directions, which resulted in multiple PCR products 
attached to a single branched nanostructure (Figure 2.11).  
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Figure 2.11: Branched PCR products. a) Illustration of Y-shaped DNA branch 
with three identical primers. All three primers are potentially extended during 
the PCR reaction, resulting in a Y-shaped PCR product. Varying the length of 
PCR template can give rise to different length arms on the Y-shaped PCR 
products. b) Electrophoresis showing extension of three identical PCR products 
from a single branch. Lane 1: 100bp ladder (Bioneer). Lane 2-6: PCR products 
using thermostable Y-shaped DNA branch with three identical primers. In each 
lane, a different length PCR template was used. Lanes 2 – 6 used template 
lengths of approximately 90, 250, 500, 750, and 1000, respectively. Distribution of 
PCR products was obtained, in which some Y-shaped DNA exhibited elongation 
of only one primer, some exhibited elongation of two primers, and some 
exhibited elongation of all three primers. 
 
These branched PCR products were further confirmed by atomic force 
microscopy (AFM) single molecule imaging,[29] which clearly indicated that 
multiple products were amplified directly from a Y-shaped branch (Figure 2.12). 
These images also show that the lengths of PCR products can be controlled by 
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designing the PCR template accordingly. We further demonstrated the controlled 
attachment of three different PCR products on single Y-shaped branch (Figure 
2.13). 
 
 
Figure 2.12: AFM of branched PCR products. Top: Illustration of starting 
reagents (branched forward primers and linear reverse primers) for modular 
primer extension via branched PCR. PCR products yield three elongated 
products attached to a single Y-shaped branch. Bottom: AFM images of branched 
structures extended via PCR. From left to right, the images show Y-shaped PCR 
products with 90 base pairs (bp), 250 bp, 500 bp, and 1000 bp arms, respectively. 
AFM topography images were post-processed with Gwyddion 2.30 software 
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using two-dimensional fast Fourier transform (2D FFT) filtering as well as 
conservative denoise and Gaussian blurring filter tools. 
 
 
 
 
Figure 2.13: Controlled extension of branched PCR products. Gel electrophoresis 
shows the controlled attachment of specific PCR products, using a branched 
structure with three different primers. Lane 1: Y-shaped DNA branch, with three 
different primers. Each primer corresponds to a different PCR template. Lane 2-4: 
In the presence of each individual template, the corresponding primer was 
extended specifically. Lane 5-7: When using a combination of two templates in 
the same PCR, the two corresponding primers were extended specifically. Lane 
8: Finally, in the presence of all three templates, all three products were 
amplified on a single Y-shaped branch. 
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 Further utilizing our branched PCR, we linked multiple Y-shaped DNA branches 
together to form an interlinked three-dimensional network, which resulted in a 
bulk hydrogel. To the best of our knowledge, this is the first time a bulk hydrogel 
has been produced entirely from PCR processes. More specifically, we designed 
two modular primers: one contained three forward linear primers (red color, 
Figure 2.14), and the other contained three reverse linear primers (green color, 
Figure 2.14). During the PCR process, these primers were extended to form 
connections among the Y-shaped DNA branches. As a result, the PCR products 
formed a networked structure (Figure 2.14 and Figure 2.16), in which the Y-
shaped DNA branches acted as cross-linking points within the network. We 
carreid out mechanical testing of this DNA hydrogel and determined the 
Young’s modulus of approximately 1.4 kPa, as shown in Figure 2.15, which was 
in agreement with previous reports on DNA hydrogels and roughly equivalent 
to the mechanical strength of a 0.5% agarose gel. 
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Figure 2.14: Formation of DNA hydrogel via PCR. PCR-generated hydrogel 
remains trapped in well during gel electrophoresis. Lane 1: 100 bp DNA ladder.  
Lane 2: Branched PCR product. Resulting PCR-generated hydrogel was stained 
with GelGreen and photographed in solution under UV illumination.  
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Figure 2.15: Mechanical testing of the PCR-generated hydrogel. (a) For this 
testing we employed a micro-mechanical analyzer (FT-S100 Microforce Sensing 
Probe, FemtoTools) as illustrated in the photograph. (b) We obtained an 
indentation curve of force per unit displacement (black line; linear region 
corresponds to approximately 0.3540 N/m). We applied the Hertz model treating 
the probe as a conical tip (D. C. Lin, E. K. Dimitriadis, F. Horkay, J Biomech Eng. 
2007, 129, 430 – 440) and obtained an estimate of Young’s modulus of 1.4 kPa 
(red line fit) which is comparable to previous works on DNA hydrogels (Y. Xing, 
E. Cheng, Y. Yang, P. Chen, T. Zhang, Y. Sun, Z. Yang, D. Liu, Adv. Mater. 2011, 
23, 1117–21; S. H. Um, J. B. Lee, N. Park, S. Y. Kwon, C. C. Umbach, D. Luo, Nat. 
Mater. 2006, 5, 797–801). 
 
This PCR-generated hydrogel can be encoded with genetic information (by 
amplifying genes as the PCR template), and the resulting hydrogel could then be 
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utilized for cell-free protein expression. Indeed, substantial production of a 
reporter protein, green fluorescent protein (GFP), was observed within the gel 
after we incorporated GFP gene into the PCR with modular primers and carried 
out in vitro expression (Figure 2.17). This approach is analogous to our previous 
work on cell-free expression with DNA hydrogels, but uses PCR rather than 
ligation as the mechanism for introducing genes into the gel.[29], [30] This 
confirmed that branched PCR with modular primers can create a generic 
structure while simulateously incorporating the genetic functions of the resulting 
PCR products. 
 
 
a b
 
Figure 2.16: PCR-generated DNA hydrogel containing gene. Modular primers 
were prepared to form an aggregate structure using GFP gene as a template. (a) 
All three arms of the Y-shaped modular primer could be extended during the 
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PCR process, resulting in a highly interconnected extended network structure. b) 
Photograph of bulk scale PCR-generated DNA hydrogel with excess solution 
removed in an inverted vial under UV illumination. The green color in this 
image is due to fluorescence from DNA-specific dye (GelGreen). 
 
Figure 2.17: Cell free expression using PCR-generated DNA hydrogel. Modular 
primers were prepared to form a hydrogel using GFP gene as a template. The 
resulting PCR-generated DNA hydrogel was used for cell-free protein 
production. The resulting expression indicated enhancement of protein 
production from the PCR-generated hydrogel in comparison with a solution 
phase system (SPS). 
 
2.5 Conclusion 
In conclusion, we have developed thermostable branched DNA nanostructures. 
These structures can be utilized as modular primers for branched PCR, allowing 
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us to take advantage of both the self-assembly and biological capabilities of DNA 
in a single PCR process. This branched PCR enabled the attachment of multiple 
moieties, such as fluorescence dyes and genes, onto a single branched PCR 
product, as well as the production of a PCR-generated DNA hydrogel. We expect 
this modular primer system to be further expanded to utilize branched PCR with 
more complicated DNA-based nanoarchitectures, such as DNA origami, DNA 
canvas, or molecular devices,[6], [7] and we envision that thermostable DNA 
nanostructures will have great utility for DNA-based materials in real world 
applications. 
 
2.6 References 
[1] N. C. Seeman, “DNA in a material world.,” Nature, vol. 421, no. 6921, pp. 
427–31, Jan. 2003. 
[2] U. Feldkamp and C. M. Niemeyer, “Rational design of DNA 
nanoarchitectures.,” Angewandte Chemie International Edition, vol. 45, no. 12, 
pp. 1856–76, Mar. 2006. 
[3] J. Bath and A. J. Turberfield, “DNA nanomachines.,” Nature 
Nanotechnology, vol. 2, no. 5, pp. 275–84, May 2007. 
[4] A. V. Pinheiro, D. Han, W. M. Shih, and H. Yan, “Challenges and 
opportunities for structural DNA nanotechnology,” Nature Nanotechnology, 
vol. 6, no. 12, pp. 763–772, Nov. 2011. 
[5] S. Peng, T. L. Derrien, J. Cui, C. Xu, and D. Luo, “From Cells to DNA 
materials,” Materials Today, vol. 15, no. 5, pp. 190–194, 2012. 
46 
 
[6] P. W. K. Rothemund, “Folding DNA to create nanoscale shapes and 
patterns.,” Nature, vol. 440, no. 7082, pp. 297–302, Mar. 2006. 
[7] B. Wei, M. Dai, and P. Yin, “Complex shapes self-assembled from single-
stranded DNA tiles.,” Nature, vol. 485, no. 7400, pp. 623–6, May 2012. 
[8] C. Zhang, C. Tian, F. Guo, Z. Liu, W. Jiang, and C. Mao, “DNA-directed 
three-dimensional protein organization.,” Angewandte Chemie International 
Edition, vol. 51, no. 14, pp. 3382–5, Apr. 2012. 
[9] S. Hamada and S. Murata, “Substrate-assisted assembly of interconnected 
single-duplex DNA nanostructures.,” Angewandte Chemie International 
Edition, vol. 48, no. 37, pp. 6820–3, Jan. 2009. 
[10] C. G. Evans, R. F. Hariadi, and E. Winfree, “Direct atomic force microscopy 
observation of DNA tile crystal growth at the single-molecule level.,” J Am 
Chem Soc, vol. 134, no. 25, pp. 10485–92, Jun. 2012. 
[11] Y. Fu, D. Zeng, J. Chao, Y. Jin, Z. Zhang, H. Liu, D. Li, H. Ma, Q. Huang, K. 
V Gothelf, and C. Fan, “Single-step rapid assembly of DNA origami 
nanostructures for addressable nanoscale bioreactors.,” J Am Chem Soc, vol. 
135, no. 2, pp. 696–702, Jan. 2013. 
[12] C. Lin, R. Jungmann, A. M. Leifer, C. Li, D. Levner, G. M. Church, W. M. 
Shih, and P. Yin, “Submicrometre geometrically encoded fluorescent 
barcodes self-assembled from DNA.,” Nature Chemistry, vol. 4, no. 10, pp. 
832–9, Oct. 2012. 
[13] C. M. Niemeyer, M. Adler, and R. Wacker, “Detecting antigens by 
quantitative immuno-PCR.,” Nature Protocols, vol. 2, no. 8, pp. 1918–30, Jan. 
2007. 
[14] B. Li, X. Chen, and A. D. Ellington, “Adapting enzyme-free DNA circuits to 
the detection of loop-mediated isothermal amplification reactions.,” 
Analytical Chemistry, vol. 84, no. 19, pp. 8371–7, Oct. 2012. 
[15] L.-L. Li, P. Wu, K. Hwang, and Y. Lu, “An Exceptionally Simple Strategy 
for DNA-Functionalized Up-Conversion Nanoparticles as Biocompatible 
Agents for Nanoassembly, DNA Delivery, and Imaging.,” J Am Chem Soc, 
vol. 135, no. 7, pp. 2411–4, Feb. 2013. 
47 
 
[16] C. K. McLaughlin, G. D. Hamblin, K. D. Hänni, J. W. Conway, M. K. 
Nayak, K. M. M. Carneiro, H. S. Bazzi, and H. F. Sleiman, “Three-
dimensional organization of block copolymers on ‘DNA-minimal’ 
scaffolds.,” J Am Chem Soc, vol. 134, no. 9, pp. 4280–6, Mar. 2012. 
[17] Y. Xing, E. Cheng, Y. Yang, P. Chen, T. Zhang, Y. Sun, Z. Yang, and D. Liu, 
“Self-assembled DNA hydrogels with designable thermal and enzymatic 
responsiveness.,” Advanced Materials, vol. 23, no. 9, pp. 1117–21, Mar. 2011. 
[18] S. H. Um, J. B. Lee, N. Park, S. Y. Kwon, C. C. Umbach, and D. Luo, 
“Enzyme-catalysed assembly of DNA hydrogel.,” Nature Materials, vol. 5, 
no. 10, pp. 797–801, Oct. 2006. 
[19] J. B. Lee, S. Peng, D. Yang, Y. H. Roh, H. Funabashi, N. Park, E. J. Rice, L. 
Chen, R. Long, M. Wu, and D. Luo, “A mechanical metamaterial made 
from a DNA hydrogel.,” Nature Nanotechnology, vol. 7, no. 12, pp. 816–20, 
Dec. 2012. 
[20] G. D. Cimino, H. B. Gamper, S. T. Isaacs, and J. E. Hearst, “Psoralens as 
photoactive probes of nucleic acid structure and function: organic 
chemistry, photochemistry, and biochemistry.,” Annual Review of 
Biochemistry, vol. 54, pp. 1151–93, Jan. 1985. 
[21] M. Tagawa, K. Shohda, K. Fujimoto, and A. Suyama, “Stabilization of DNA 
nanostructures by photo-cross-linking,” Soft Matter, vol. 7, no. 22, p. 10931, 
2011. 
[22] A. Rajendran, M. Endo, Y. Katsuda, K. Hidaka, and H. Sugiyama, “Photo-
cross-linking-assisted thermal stability of DNA origami structures and its 
application for higher-temperature self-assembly.,” J Am Chem Soc, vol. 
133, no. 37, pp. 14488–91, Sep. 2011. 
[23] J. K. Lee, Y. H. Jung, J. B.-H. Tok, and Z. Bao, “Syntheses of organic 
molecule-DNA hybrid structures.,” ACS Nano, vol. 5, no. 3, pp. 2067–74, 
Mar. 2011. 
[24] S. Keller, J. Wang, M. Chandra, R. Berger, and A. Marx, “DNA polymerase-
catalyzed DNA network growth.,” J Am Chem Soc, vol. 130, no. 40, pp. 
13188–9, Oct. 2008. 
48 
 
[25] J. K. Lee, Y. H. Jung, R. M. Stoltenberg, J. B.-H. Tok, and Z. Bao, “Synthesis 
of DNA-organic molecule-DNA triblock oligomers using the amide 
coupling reaction and their enzymatic amplification.,” J Am Chem Soc, vol. 
130, no. 39, pp. 12854–5, Oct. 2008. 
[26] Y. Li, Y. D. Tseng, S. Y. Kwon, L. D’Espaux, J. S. Bunch, P. L. McEuen, and 
D. Luo, “Controlled assembly of dendrimer-like DNA.,” Nature Materials, 
vol. 3, no. 1, pp. 38–42, Jan. 2004. 
[27] J. B. Lee, Y. H. Roh, S. H. Um, H. Funabashi, W. Cheng, J. J. Cha, P. 
Kiatwuthinon, D. A. Muller, and D. Luo, “Multifunctional 
nanoarchitectures from DNA-based ABC monomers.,” Nature 
Nanotechnology, vol. 4, no. 7, pp. 430–6, Jul. 2009. 
[28] Y. Li, Y. T. H. Cu, and D. Luo, “Multiplexed detection of pathogen DNA 
with DNA-based fluorescence nanobarcodes.,” Nature Biotechnology, vol. 
23, no. 7, pp. 885–9, Jul. 2005. 
[29] N. Park, S. H. Um, H. Funabashi, J. Xu, and D. Luo, “A cell-free protein-
producing gel.,” Nature Materials, vol. 8, no. 5, pp. 432–7, May 2009. 
[30] N. Park, J. S. Kahn, E. J. Rice, M. R. Hartman, H. Funabashi, J. Xu, S. H. 
Um, and D. Luo, “High-yield cell-free protein production from P-gel.,” 
Nature Protocols, vol. 4, no. 12, pp. 1759–70, Jan. 2009.  
 
49 
 
CHAPTER 3 
POINT-OF-CARE NUCLEIC ACID DETECTION 
 
3.1 Challenge of point-of-care diagnostics 
Recent developments in nanotechnology have led to significant advancements in 
point-of-care (POC) nucleic acid diagnostics. The ability to sense DNA and RNA 
in a portable format will play a key role in personalized medicine with important 
applications for a range of clinical and non-clinical settings in both the 
developing and developed world. In this chapter, nanotechnology-driven 
innovations are discussed in the context of three key process components for 
nucleic acid detection: sample preparation, target amplification, and 
detection/read-out modalities. The advancements realized by nanotechnology 
are making POC nucleic acid detection increasingly prevalent, and 
revolutionizing diagnosis to shift toward more personalized and decentralized 
testing. 
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3.2 Introduction and background for point-of-care (POC) detection 
Point-of-care (POC) diagnosis, testing carried out at or near the site of the 
patient, is an extremely attractive concept for expanding the access and efficiency 
of diagnostic testing beyond hospitals and centralized laboratory-based testing. 
POC detection can be particularly valuable for developing world or resource-
limited settings.[1–3] In the developing world context, portable diagnosis could 
offer increased access to tests for infectious diseases such as HIV, malaria, 
tuberculosis, and sexually transmitted infections.[4] In addition, POC detection is 
of growing importance for the developed world, for contexts such as at-home 
care and minimally complex and equipment-free tests that could someday be 
offered at the drug store or basic clinic.[5–8] Furthermore, the technology 
developed for POC detection covers a broad range of applications, as 
represented in Figure 3.1, including testing in agriculture (crops and food 
supply), veterinary medicine and animal health (pets and livestock), and in the 
environment (air, soil, and water contamination).[1], [9], [10] 
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 Figure 3.1: The “5 W’s” regarding POC diagnosis of nucleic acids. With 
applications extending well beyond the limits of conventional hospital and 
laboratory-based testing, the potential scope of POC detection is remarkably 
broad. The “how” of POC detection, absent from this figure, constitutes the main 
subject of this chapter. 
 
POC detection for nucleic acids is of particular interest given the extreme 
importance of DNA and RNA as diagnostic targets with applications ranging 
from genotyping and genetic prognostics, to expression profiling and detection 
of infectious disease.[11–15] In current clinical practice, nucleic acid diagnostics 
are widely used for situations involving infectious disease and cancer (e.g. tumor 
genotyping).[16], [17] Nucleic acid-based testing is a popular and preferred 
method for monitoring epidemics and outbreaks of new diseases (e.g. 
H7N9).[18], [19] Compared to immunological biomarkers, nucleic acids have 
several important practical advantages, including: (1) straightforward design of 
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specific recognition elements (primers and probes) with predictable behaviors 
and binding affinities, and (2) straightforward compatibility with enzymatic 
target amplification methods such as PCR, which enable nucleic acid detection to 
be extremely sensitive. 
POC detection represents a complex engineering challenge that will benefit from 
nanotechnology-enabled functionalities and capabilities, as shown in Figure 3.2. 
For example, metal nanoparticles (e.g. gold nanoparticles) have been widely used 
for biosensing applications,[20], [21] due to their unique characteristics such as 
their high degree of polyvalency and plasmonic properties.[22] As another 
example, DNA-based nanostructures have been designed in a controlled fashion 
to form nanoscale shapes and patterns, which interfaced directly with target 
nucleic acids for detection applications.[23–25] In addition, DNA 
nanotechnology can be utilized in the creation of hybridization-based circuits 
and reaction networks and DNAzymes and RNAzymes for non-enzymatic target 
and signal amplification.[26] Other engineered nanomaterials such as carbon 
nanotubes and nanowires have been utilized for highly sensitive optical and 
electrical sensing.[27] Quantum dots and other nanomaterials have been widely 
used as superior labels and contrast agents for fluorescent detection and 
diagnostic imaging[28–30] as wells as for detection of proteins and small 
molecules.[20], [31], [32] In general, nanoscale materials have higher surface-to-
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volume ratios, associated with improved catalytic and binding properties, which 
can facilitate enhanced transduction of target-binding events into signals.[33], 
[34] This has been utilized for improved binding and transport properties in 
nanoporous materials such as hydrogels and polymeric and metal/metal-oxide 
solid supports.[35–39] Overall, nanotechnology is poised to play a key role in the 
development of next generation POC technologies.[40–43] 
 
 
Figure 3.2: A sampling of nanotechnology concepts and nanomaterials that have 
been utilized for POC nucleic acid detection. 
 
The ideal portable detection method will meet all the requirements of traditional 
centralized laboratory-based testing, while also overcoming the additional 
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challenges associated with POC testing, such as uncontrolled environmental 
conditions (temperature and humidity), inconsistent or non-existent electrical 
power supply, non-sterile conditions, and operation by untrained or minimally 
trained personnel. The attributes generally required for POC detection are 
illustrated by the ASSURED criteria, as represented in Figure 3.3.[3] These 
criteria emphasize the range of priorities required for consideration in the 
development of innovative and efficient POC methods and devices. Whenever 
possible, POC devices should involve low cost materials, minimally complex 
procedures and equipment requirements, and reliable performance even under 
less-than-ideal operating conditions. Devices that do not satisfy the ASSURED 
criteria may be poorly-suited for implementation in the field. This review 
highlights a representative sampling of the diverse innovations that have been 
developed to satisfy the POC ASSURED criteria, which can act as component 
technologies for design of the ideal POC detection device. 
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 Figure 3.3: The ASSURED criteria for POC detection, as originally developed by 
the World Health Organization. We note that these criteria are not meant to be 
limiting, and viable technical options outside the scope of these guidelines may 
still be worth pursuing. 
 
We structure this review to reflect the three distinct operational steps that are 
typically required for POC detection: sample preparation and processing, target 
amplification, and detection and read-out (Figure 3.4). Although each step can be 
considered individually, it is important to emphasize that the key challenge for 
development of POC nucleic acid diagnostic methods is the integration of all 
these key steps into a unified process workflow and preferably within a single 
device. 
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 Figure 3.4: The outline of this review is based on the three distinct operational 
steps that are typically required for POC detection: sample preparation and 
processing, target amplification, and signal detection and read-out. The ideal 
POC nucleic acid diagnostic device will smoothly integrate these key steps into a 
single process. 
 
3.3 Sample Preparation 
Sample preparation has been recognized as one of the most critical 
considerations for effective nucleic acid POC diagnostics.[44–49] The primary 
challenge of sample preparation is the diversity of sample types. Test specimens 
may be collected from a broad range of sources, including: human or animal (e.g. 
body fluids, swabs, or tissue samples), plant, cell or virus culture, and 
environmental samples (e.g. water, soil, or air). The samples of interest may also 
have a diverse range of physical and chemical characteristics (e.g. viscosity, pH, 
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salinity), requiring a variety of approaches for sample collection and 
pretreatment. For example, in some specimens (e.g. stool or soil), most of the 
sample may consist of solid content, thus requiring additional sample dilution 
and pretreatment. 
In most cases, sample preparation involves lysis in order to disrupt the target 
cells (e.g. pathogenic virus or bacteria) and release nucleic acid material.[50] 
Lysis is most commonly carried out through chemical means using denaturants, 
but may also be accomplished through freeze-thawing, sonication, heating, and 
other methods. Near infrared heating of gold nanorods has been utilized to 
achieve one step DNA extraction and real-time PCR of pathogens in a single 
chamber.[51] It is also important to note that in some detection scenarios, lysis is 
unnecessary; for example, certain nucleic acids associated with cancer can 
circulate in the blood stream, and cell-free nucleic acids may also be present in 
the urine.[52–54]  
Following sample lysis, nucleic acid material is typically purified from the 
remainder of the sample. Purification is required for consistent performance of 
downstream amplification and detection read-out steps. In particular, untreated 
samples frequently contain inhibitors that interfere with PCR or other target 
amplification processes.[55] Purification is also an opportunity for target 
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enrichment, which is beneficial because nucleic acid concentrations in native 
samples may be insufficient for sensitive detection. Through enrichment, the 
concentration of nucleic acids can be increased and milliliter sample volumes can 
often be reduced to tens of microliters. Sample purification is also important for 
maintaining the integrity of the target nucleic acid by removing or inhibiting 
nucleases; this is particularly important for RNA, which is easily degraded in 
complex media. By far the most common method for nucleic acid purification 
and enrichment is the Boom method, due to its convenience and effectiveness to 
obtain highly pure product.[56] This is a solid phase extraction (SPE) method in 
which (1) the test sample is mixed with a chaotropic agent that simultaneously 
denatures proteins and facilitates nucleic acid binding to a solid phase (usually 
silica), (2) the bound nucleic acid is washed to remove components of the original 
sample other than nucleic acid, and (3) the nucleic acid is eluted at a higher 
concentration in sterile buffer.  
To carry out the Boom method, one common approach is to pass lysed samples 
and wash buffers over the solid phase via some actuation force. This approach is 
currently used in a large number of nucleic acid purification devices, in which 
the actuation force can be pressure,[57–59] capillary force,[60], [61] or centrifugal 
force.[62], [63] There is an increased advantage in the use of micro- and nano-
structured materials, which can offer higher surface areas for increased binding 
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of nucleic acids.[64] For example, a nanoporous monolithic aluminum oxide 
membrane (AOM) was used for DNA extraction and real-time polymerase chain 
reaction (RT-PCR) amplification of the extracted DNA.[65] In this work, lysed 
samples were filtered through the nanoporous AOM to extract the DNA. PCR 
reagents were added to each of the wells and the chip was thermocycled directly 
on the AOM membrane.  
Another strategy for purification uses magnetic microparticles to capture nucleic 
acids. For example, iron core microparticles coated with a nanometer layer of 
silica are commercially available.[66] After binding to nucleic acids, these beads 
can be magnetically trapped as wash and elution buffers are passed over the 
bead surface. The use of a magnet is extremely compatible for POC applications. 
For example, Duarte and coworkers demonstrated a sample preparation device 
that used external magnets to generate movement of magnetic beads through a 
micro-chamber, ensuring thorough sample mixing and increasing interaction 
with the beads.[67] This approach has also been used with pinned immiscible 
interfaces in microchannels, for which either air/liquid or oil/aqueous interfaces 
can be used. These interfaces act as barriers, separating the lysis and elution 
chambers and preventing mixing of these two solutions.[68–71] This method 
streamlines the extraction process, replacing all washing steps with a single 
traverse of the immiscible barrier. 
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 3.4 Target Amplification Strategies 
Once sample preparation (process step one, as in Figure 3.4) is completed, 
nucleic acid detection often requires some form of target amplification (process 
step two) in order to obtain clinically relevant sensitivity from small amounts of 
samples.[72–74] This target amplification step introduces substantial operational 
complexity to the nucleic acid detection process, and is therefore undesirable. If 
the target amplification process is eliminated altogether this may be referred to 
as “direct detection” of nucleic acids. Direct detection methods greatly simplify 
the diagnostic procedure but require extremely sensitive read-out to accurately 
detect the non-amplified nucleic acid target. Direct detection of nucleic acids 
must overcome fundamental problems including (1) low signal requiring 
extremely sensitive signal amplification, and (2) low target concentrations 
leading to slow reaction kinetics. Thus, despite the added process complexity 
associated with target amplification, most nucleic acid detection strategies are 
well-justified in their use of target amplification in order to overcome these 
problems. 
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3.4.1 Enzyme-based target amplification: PCR and isothermal amplification 
methods 
This target amplification process usually involves an enzymatic reaction such as 
polymerase chain reaction. Due to the popularity of PCR as a target amplification 
technique in clinical and laboratory settings, PCR has been widely adapted and 
implemented in POC detection as well.[75], [76] In the commercial context, 
Cephied’s GeneXpert is an FDA-approved benchtop system that utilizes PCR 
and enjoys widespread use.[77] Taking advantage of the microfluidic format that 
is widely used for POC diagnostics, significant work has been done to increase 
the speed of portable PCR, which could potentially offer rapid results to 
patients.[78] Using these and other innovations, PCR-based POC methods have 
demonstrated great success.[65], [79] Nevertheless, the thermal cycling required 
by PCR (necessitating heaters, temperature sensors, and increased process and 
device complexity) represents an obstacle for POC. Thus, a substantial amount of 
work has focused on the development of techniques that avoid the thermal 
cycling requirement. I will briefly discuss non-PCR target amplification methods 
including isothermal amplification and non-enzyme amplification, because these 
methods are more amenable to POC detection. In particular, I will describe the 
use of nanotechnology innovations (e.g. DNA-based reaction networks that has 
developed from DNA nanotechnology) for non-enzymatic target amplification as 
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a particular area of interest. 
Unlike PCR, isothermal amplification methods are designed so that amplification 
occurs at one constant temperature. This modification translates into fewer 
equipment requirements, making isothermal amplification ideal for integration 
into microfluidic devices for POC applications. Several different isothermal 
amplification methods are available, and I will briefly address some of the most 
popular, including LAMP, NASBA, RCA, and HDA (Figure 3.5).[74] 
Loop mediated isothermal amplification (LAMP) is an increasingly popular 
technique for POC applications; it has the advantage of being performed at a 
single temperature with only one type of enzyme. The LAMP procedure uses 
four primers and polymerase with strand displacement activity to achieve a 
cyclical amplification process based on spontaneous formation of stem-loop 
DNA structures.[80] The LAMP method has a reputation for being rapid (<1 
hour) and has a relatively broad working range (60-65˚C) which reduces the need 
for highly stable heating devices, making it an attractive method for POC 
diagnostics. As a result there are many examples of various LAMP assays which 
have been developed for resource poor areas.[81–84] Extent of the reaction can be 
determined by measuring the turbidity of the reaction solution or via an 
intercalating DNA dye like SYBR GREEN I.[85] One challenge of the LAMP 
62 
 
method is false positive results deriving from accidental amplification of non-
target DNA sequences. To overcome this drawback, researchers have 
incorporated sequence-specific fluorescent probes such as molecular beacons to 
add an additional layer of specificity.[86] 
Nucleic acid sequence based amplification (NASBA)[87] is a well-established 
isothermal amplification technique that offers excellent amplification of RNA 
sequences, producing single-stranded RNA products. Compared to other target 
amplification methods, NASBA is a popular choice because it can detect single-
stranded RNA, and because it generates single-stranded RNA products that 
allow for convenient hybridization in downstream detection steps. Using a 
mixture of reverse transcriptase, primers, RNase H, and T7 RNA polymerase, 
NASBA amplifies single stranded RNA sequences by cyclically (1) forming 
DNA:RNA hybrids with reverse transcriptase, (2) degrading the RNA with 
RNase H, (3) creating dsDNA using with reverse transcriptase, and (4) and 
generating many copies of single-stranded RNA with RNA polymerase. NASBA 
requires three different enzymes (reverse transcriptase, RNAse H, and RNA 
polymerase), which may increase procedural complexity. Zhao et al, used 
NASBA to create is a low cost and potentially disposable device which can detect 
down to 64 cells in a liter of solution.[88] NASBA has also been used for the 
simultaneous amplification of mRNA and miRNA, which may make it an 
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excellent process for screening for indicators of cancer.[89] 
Rolling circle amplification (RCA) utilizes a DNA polymerase with strand-
displacement activity to continuously elongates a hybridized primer from a 
circular DNA template.[90], [91] This process results in long DNA repeats which 
can be labeled with DNA-binding dyes. The most distinctive aspect of RCA is the 
requirement for a circular template for amplification, which makes RCA 
uniquely well suited for amplification of naturally circular DNA molecules such 
as plasmids and certain virus genomes. RCA can also detect linear DNA, but 
requires an additional circularization step; this step increases specificity but 
increases process complexity. Alternately, the target nucleic acid can be utilized 
as a primer to initiate the RCA process. To increase sensitivity, repeated hairpin 
formation within the RCA products has been used to increase signal by forming 
dsDNA which has a high affinity for DNA dyes like SYBR green [92]. To further 
increase the speed of target amplification, additional primers can be utilized to 
bind to the repeating sequences in the RCA product (called branching RCA, or 
geometrical RCA), triggering additional amplification to improve the 
performance of POC detection. This can yield 109 or more copies of the template 
in under an hour and has been shown to detect as few as ten molecules.[93] In 
another strategy, RCA was used to detect miRNA to generate a single-stranded 
product containing DNAzyme, giving rise to a color signal.[94]  
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Helicase dependent amplification (HDA) mimics nature by utilizing helicase to 
separate double stranded DNA.[95] Thus, HDA is uniquely well-suited for 
detection of double-stranded DNA targets since it does not require any initial 
heat denaturation step. In many cases, HDA has exhibited a detection limit 
ranging from 10 to 103 DNA copies in under an hour.[96–99] A notable example 
of a HDA based system was produced by Kivlehan et al. in which real-time 
electrochemical monitoring was enabled using an intercalating redox probe.[100] 
Mahalanabis and coworkers demonstrated HDA in a device that integrated 
bacterial lysis, nucleic acid extraction, and detection with a fluorescent reporter, 
achieving detection of down to ten colony forming units of E. coli.[59] In another 
example of HDA-based detection for POC, Huang et al achieved complex sample 
preparation and DNA amplification using only simple materials and no external 
electrical power.[58] 
Aside from the isothermal amplification methods highlighted above, a wide 
variety of additional methods have also been reported, including transcription-
mediated amplification (TMA),[101] strand displacement amplification 
(SDA),[102] multiple strand displacement (MDA, often used for nonspecific 
amplification of genomic DNA),[103] recombinase polymerase amplification 
(RPA),[104] and cross priming amplification (CPA)[105], among many 
others.[106]  This growing collection of isothermal amplification techniques may 
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serve as a library of candidates for incorporation into any potential POC nucleic 
acid detection device. 
 
 
Figure 3.5: Schematics of several of the most popular isothermal target 
amplification methods for nucleic acid amplification. NASBA is well-established 
for amplification of RNA targets. LAMP requires only one single enzyme (most 
isothermal amplification methods require at least two). RCA works best for 
detection of circular and single-stranded DNA targets. HDA, inspired by nature’s 
method for DNA replication, uses helicase to unwind DNA. 
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3.4.2 Non-enzymatic target amplification 
Although enzymes, particularly polymerases, are effective for target 
amplification of nucleic acids, they introduce certain challenges for POC 
detection. Specifically, enzymes are often unstable at POC settings because they 
require special conditions including refrigeration for transport, storage, and 
handling. Because of these drawbacks, enzyme-free methods have attracted a 
great deal of attention for POC detection.  
Current enzyme-free methods are mostly motivated by academic interest and 
carried out in laboratory settings and not POC; however, the technology is 
promising for POC applications due to the predictability of reactions that are 
mainly based on hybridization of nucleic acids. Nevertheless, these non-
enzymatic technologies represent one important area where nanotechnology 
(particularly DNA and RNA nanotechnology) can play a critical role in the 
development of novel POC diagnostics. In particular, we focus on DNA 
hybridization-based methods as the amplification mechanism. 
The basic mechanism for achieving DNA-based chain reactions using strand 
displacement concepts was introduced by Yurke et al.[107] Through strand 
displacement, a partially hybridized strand is exchanged into a fully hybridized 
strand using a single-stranded region (toehold) as a starting point.  Seelig and 
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coworkers improved upon this idea by creating a metastable DNA fuel complex, 
which increased the stability of the fuel strands about two orders of 
magnitude.[108] This design was later adapted to the input signal amplifier of 
DNA logic gates.[109] Recently, large-scale DNA logic gates with signal 
amplification were realized by Qian and Winfree.[110] In order to obtain more 
rapid signal amplification, autocatalysis has been used to attain an acceleration 
of signal amplification, through which a repetitive reaction increased the number 
of catalysts.[111]  These implementations show the robustness of DNA-based 
logic gates and amplification techniques even in large scales, which can be used 
as a strong and reliable methodology for future POC diagnostics. 
Hairpin motifs are also widely used in this field. One approach towards 
amplification using this motif is to produce long output double strands triggered 
by inputs, instead of the increase in concentration. Hybridization chain reaction 
(HCR) achieves this using single stranded DNA as a trigger to produce long 
double-stranded DNA.[112] This system was also implemented in situ, using it as 
an imaging technique for mRNA expression in zebrafish embryos.[113] This 
example, which succeeded in practical environment, clearly indicates the 
amplification of the signal (and also detection) is also possible for POC as well. 
Yin and colleagues used the hairpin motif to design diverse types of reactions 
based on simple but powerful methodology.[114] Moreover, Li et al. reported 
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several hairpin-based reactions that including amplification and also showed 
that the reaction could be used for the detection of RNA and small molecules in a 
modular fashion.[115] These series of examples demonstrated the potential of the 
hairpin-based motifs towards actual use in POC diagnostics in terms of 
robustness and modularity. 
Isothermal amplification strategies can be used in conjunction with non-
enzymatic DNA hybridization-based strategies, in a combined approach.[116] 
For example, Allen and coworkers used a catalytic hairpin assembly (CHA)-
based device was combined with paper fluidics to create an ultra-cheap and 
portable device.[117] Similarly, by combining LAMP with CHA-based non-
enzymatic circuit, Li and coworkers increased the specificity of the LAMP 
reaction by introducing an “AND” gate, and detected as few as 10 molecules per 
microliter.[118] 
 
3.5 Detection  
Following target amplification (operational step two, as shown in Figure 3.4), the 
amount of target should be sufficient for actual detection to finally occur 
(operation step three). This step introduces many opportunities for 
nanotechnological innovations. Nanomaterials can function as labels for 
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fluorescence or electrochemical detection. Nanofunctionalized sensing surfaces 
can enable higher binding capacities or other unique properties. Nanoscale 
phenomenon such as fluorescence transfer resonance and plasmon resonance can 
also be utilized for detection. We address detection in three broad strategies for 
sensing and read-out: naked eye detection (based on lateral flow assay and NP 
aggregation technologies), optical detection, and electrochemical-based 
strategies. 
 
3.5.1 Naked eye detection 
The lateral flow assay (LFA) is the most widely used commercially available 
POC diagnostic format today.[9], [119] It has the key advantages of low cost, 
high speed, and simple format and readout – all of which make it one of the most 
promising POC platforms for both developing and developed worlds. A 
widespread example of a successful, commercially-available LFA product is the 
home pregnancy test device, which not only comes in a simple test-strip format 
but can be used by virtually anyone with little to no prior training. In addition to 
confirming pregnancy, LFA devices have also been developed for infectious 
disease detection, drug abuse screening, and rapid clinical diagnosis of serious 
health events such as heart attacks and strokes. Traditionally, LFA devices have 
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been used for immunological detection, but they have also been adapted for 
nucleic acid-based detection as well.[120] For example, Baumner and co-workers 
demonstrated nucleic acid detection in a test strip format with nanomolar 
detection limits,[121] and Carter and Cary demonstrated amplification in an LFA 
format using latex microparticles.[122] Many of the concepts and technologies of 
LFA have recently been extended and utilized in the context of paper-based 
microfluidics.[123] 
In general, LFA devices are chromatographic platforms which contain 
functionalized particles (e.g. gold nanoparticles, latex beads, or liposomes) that 
bind to particular analytes in a given sample.[124] The analyte-particle complex 
subsequently flows laterally, driven by capillary force, through a series of 
overlapping membranes within the device and is finally captured in a “readout” 
portion of the device. A visual result (i.e. colored band) is usually achieved 
within a few minutes, which can be easily interpreted by an untrained individual 
without the need for expensive equipment. In the case of nucleic acids, LFA 
devices exploit the specificity of DNA hybridization to capture and detect nucleic 
acid targets in a manner very similar to the original LFA assays which typically 
detected antibodies or antigens. Nucleic acids can be captured on lateral flow test 
strips in several different ways. Most commonly, gold nanoparticles can be 
functionalized with single stranded DNA capture probes that will selectively 
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bind to distinct DNA targets and generate an AuNP aggregate that yields a clear 
color change in the test strip. For example, an innovative POC NALF device was 
developed by Mao and coworkers.[125] In this work a disposable nucleic acid 
biosensor strip with nanoparticle probes was used to perform low-cost and 
sensitive detection of nucleic acid targets within 15 minutes. Sandwich-type 
DNA hybridization reactions were employed to capture targets onto 
immobilized nucleic acid probes and enable gold NP binding to the captured 
targets. The concentration of gold NPs on the immobilized targets generates a 
distinct color change on the flow test strip. This detection method avoided the 
multiple incubation, separation, and washing steps that are often required for 
nucleic acid biosensors and demonstrated the successfully use of DNA-NP 
aggregates for nucleic acid detection within a lateral flow biosensor. 
To improve the sensitivity and specificity the NALF assay format, Puchang Lie 
and colleagues used an isothermal strand-displacement polymerase reaction in a 
lateral flow strip format.[126] Similarly, Rohrman and coworkers designed a 
NALF device, using gold nanoparticle probes and a gold enhancement solution 
to monitor HIV viral load in patients over a clinically relevant range.[127]  
Metal nanoparticles (particularly gold) for DNA sensing have also been utilized 
in a colorimetric detection scheme that is based on gold nanoparticles 
72 
 
aggregating together instead of binding to a surface region on a lateral flow strip. 
Similar to the LFA approach, this NP aggregation approach can potentially 
enable naked eye detection. Gold nanoparticles exhibit a color change that is 
dependent on the interparticle distances in solution. Mirkin and colleagues 
developed a colorimetric detection system utilizing gold nanoparticles 
containing surface-immobilized DNA probes that bound to DNA targets and 
yielded distinct colorimetric signals.[128] Expanding on this approach, Storhoff 
and co-workers spotted DNA-modified gold NPs onto a glass waveguide slide 
and monitored the scattering effects from the gold nanoparticles, which yields a 
yellow to orange color due to a plasmon band red shift.[129] Another innovative 
and simple method for colorimetric detection was devised by Mollasalehi et al, 
who used non-crosslinking gold nanoprobes that aggregated primarily via 
changes in ionic strength to achieve detection readouts visible to the naked 
eye.[130] In another approach that used ligation chain reaction as an 
amplification step, Shen and coworkers demonstrated gold nanoparticle 
aggregation for detection of DNA down to 20 attomolar concentration.[131] 
These examples represent how nanoparticle based colorimetric detection can 
meet POC criteria without sacrificing sensitivity or specificity. 
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3.5.2 Optical detection 
Optical detection is widely employed in laboratory-based clinical chemistry, 
typically utilizing microscopes, lasers, spectrophotometers, lenses, and ﬁlters 
that are precisely arranged and aligned in the controlled laboratory environment. 
These systems may be difficult to translate to a portable or minimal complexity 
format. Fortunately, technological progress in LEDs, laser diodes, and low-cost 
sensors, as well as the continued development of microfluidic integration and 
nanoscale materials, is leading to increased feasibility and convenience for 
optical POC detection. 
As described previously, the isothermal amplification method LAMP can be 
monitored by measuring turbidity, resulting from complex formation of 
pyrophosphate and divalent metallic ions [85] Implementing this method, Fang 
and colleagues used LAMP for viral nucleic acid detection within an 8-channel 
microfluidic chip that generated a readout that could be visualized either by 
naked eye or, for more quantitative measurements, via absorbance measured by 
an optical sensor and built-in LED.[132] As a step toward a more integrated 
LAMP device, Fang and researchers designed a LAMP microfluidic device which 
can lyse bacteria and perform LAMP reactions in parallel for multiplexed POC 
detection of bacteria.[133] Another interesting POC method incorporated both 
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fluorescence and colorimetric detection of nucleic acids, and utilized DNAzymes 
as the catalyst for a cleavage-based signal amplification scheme.[134] Other work 
has demonstrated the use of digital LAMP that could be potentially used for 
quantities nucleic acid detection. [135], [136]  
 
3.5.3 Electrochemical detection 
Electrochemistry-based DNA sensors offer important benefits for POC 
diagnostics. These sensors provide sensitivity, selectivity and low cost.  A wide 
range of chemical methods are also available for functionalizing and 
immobilizing capture probes on many types of electrode substrates, enabling 
extra versatility in the design and chemical tuning of these DNA biosensors. In 
addition, electrochemical reactions provide a direct electronic signal so the 
sensors can bypass the need for expensive signal transduction equipment. Unlike 
the optical approach, electrochemical detection usually requires electrodes to be 
interface directly with samples, which may introduce fouling or necessitate 
replacement of disposable components for each test. Electrochemical detection 
approaches can be integrated directly with additional electronic components for 
signal processing or read-out, and potentially be manufactured at low cost 
(benefitting from the existing production capabilities of the microelectronics 
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industry). 
DNA electrochemical sensors in general contain nucleic acid layers for capturing 
and detecting the nucleic acid target, and an electrochemical transducer which 
enables a simple, accurate readout directly from the electrochemical reactions 
occurring within the device. One of the important early electrochemical DNA 
biosensors was a nanoparticle-based electrical detection device which utilized 
electrochemical stripping to distinguish hybridization of a target 
oligonucleotide.[137]  Hsieh and coworkers achieved real-time quantitative 
nucleic acid detection by combining microfluidics, isothermal DNA amplification 
methods (LAMP), and electrochemical detection into a single POC device.[138]  
In another work, highly sensitive detection of DNA targets was achieved using a 
pair of interdigitated electrodes as the impedance biosensor.[139] Fang and 
coworkers developed a sensitive, PCR-free, electronic chip that performed 
multiplex detection of a panel of mRNA to screen for prostate cancer.[34] 
Another great advancement in portable electrochemical POC devices was 
demonstrated by Toumazou et al., who developed a pH-sensing, CMOS-based 
device that performs real-time detection of nucleic acids amplified via PCR or 
isothermal amplification.[140] This platform was successfully used for 
genotyping DNA from crude human saliva samples in about 30 minutes, and it 
additionally was highly sensitive and can detect low copy numbers. 
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 3.6 Conclusion and outlook 
The current generation of rapid diagnostic tests, such as the immunological tests 
for pregnancy, strep throat, and HIV, has already demonstrated the practical 
benefits as well as the marketability of POC detection technology. At the same 
time, increased popularity of molecular diagnostics for clinical applications, as 
well as the increasing popularity of next generation sequencing, is driving 
increased interest in nucleic acid based detection methods. Nucleic acid-based 
tests will grow progressively widespread as new assays are introduced for 
diseases and conditions that have traditionally relied on other diagnostic 
methods. Thus, the current research and clinical climate seems promising for 
nucleic acid diagnostics to become increasingly prevalent and relevant for POC 
detection. 
Despite this great potential, the field of POC detection of nucleic acids is still in 
its early stages. POC detection demands reliable performance and high 
sensitivity, the capacity to handle variable test samples with diverse physical and 
chemical properties, and minimal sampling handling and procedural complexity. 
To overcome these challenges, nanotechnology will undoubtedly play a key role 
in the continued development of POC assays.  Progress will rely heavily on 
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cutting edge innovations in nanotechnology including the use of metal 
nanoparticles and DNA nanostructures and reaction networks, as well as 
nanomaterials such as carbon nanotubes, nanowires, and quantum dots. These 
nanoscale technologies will provide unique capabilities to enable the next 
generation of POC nucleic acid diagnostics. 
As the portable nucleic acid detection field matures, greater emphasis must be 
placed on complete integration of technologies and validation of performance; 
the aforementioned POC ASSURED criteria may be used as guidelines for this 
development. Successfully meeting all or most of the ASSURED criteria will 
allow for important advances over a range of applications. For example, 
automated detection systems may be developed for crop and food safety, 
environmental monitoring, and bioterrorism, thus overcoming significant 
challenges in agriculture, food security, and public health and safety. To this end, 
future work will aim to achieve real-world implementation and focus on 
utilizing the platform technologies described here in conjunction with more 
realistic sample matrices and environmental conditions. By taking full advantage 
of nanotechnology innovations, devices for POC detection of nucleic acids will 
ultimately lead to substantial advancements in diagnostics and widespread use. 
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CHAPTER 4 
HYBRIDIZATION-DRIVEN AGGREGATION 
 
 
4.1 Priorities and challenges of point of care diagnostics 
Point of care (POC) detection is defined as diagnosis at or near the site of patient 
care. POC diagnostic tests could potentially offer reduced healthcare costs and 
increased access to testing, with extremely important benefits particularly for 
developing world settings.[1], [2] The development of diagnostic tests for 
resource limited settings requires a different set of characteristics and priorities 
from conventional detection methods that were originally developed to be 
carried out in more resource-rich environments. The acronym ASSURED, as 
shown in Table 4.1, is used to illustrate the attributes of a successful POC 
diagnostic test. A good example of a current detection methods that may be 
considered to meet the ASSURED criteria are immunological-based rapid tests 
such as the well-established instant pregnancy test based on detection of Human 
Chorionic Gonadotropin (hCG), which serves as a ubiquitous and popular 
demonstration of the marketability and benefits associated with POC testing. 
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Affordable 
Increase access to testing by lowering cost barrier; 
especially important for developing world setting 
Sensitive 
Detect targets down to low concentrations for 
enhanced diagnostic performance 
Specific 
Minimize false positives by selective recognition 
of the target 
User-friendly 
Low complexity assay to be carried out by 
minimally-trained personnel 
Rapid and Robust 
Deliver rapid time-to-answer, assay should be 
reliable performance even in non-ideal conditions 
Equipment-free or 
minimal equipment 
Emphasize portability and ease-of-use by 
avoiding bulky or burdensome equipment 
Delivered to the 
greatest need 
Facilitate by prioritizing easy transportation and 
storage of all components of the assay 
 
Table 4.1: The ASSURED criteria describing the idealized attributes of a 
successful POC diagnostic test. These characteristics are useful for establishing 
priorities for development of new POC diagnostic assays. 
 
However, many current diagnostic technologies require elaborate laboratory 
infrastructure, trained personnel, costly reagents, and components that require 
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special handling and storage.[3], [4]  For example, nucleic-acid amplification tests 
such as polymerase chain reaction (PCR) can identify pathogens rapidly and 
with high sensitivity. In addition, nucleic acid tests are highly specific due to 
their ability to detect pathogens based on their unique genetic makeup. 
However, most nucleic-acid amplification tests rely upon enzymatic 
amplification. These are not ideal for POC testing because enzymes are difficult 
and expensive to produce and often exhibit diminished activity under harsh 
conditions. In addition, carrying out these assays typically requires trained 
personnel and special equipment such as thermal cyclers. 
Various enzyme-free methods have been demonstrated using principles derived 
from DNA computing and self-assembly.[5–9] Another enzyme-free approach 
employed aggregation of gold nanoparticles as a sensitive amplification 
approach for nucleic acid detection.[10] Aggregation and directed assembly of 
DNA-coated microbeads has been demonstrated[11], [12] and various works 
have since been published on the assembly of nanoparticles using DNA as a 
linker.[13] 
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4.2 Polyvalent binding of reactants enables agglutination 
Agglutination is a fundamental biological process at both the micrometer and 
nanometer scale. At the micrometer scale, for example, red blood cells clump 
together in the presence of specific antibodies (hemagglutination, as occurs in a 
mixture of mis-matched blood types). This naturally-occurring process of 
agglutination has been utilized for the development of immunological bead-
based assays, which are widely used for testing blood samples. Agglutination 
typically results in the formation of large precipitates that settle out of the 
solution, and this behavior can frequently be observed by the naked eye. Thus, 
agglutination is a convenient approach for diagnostics, because the clumping 
reaction occurs rapidly and is straightforward both to produce and to interpret. 
At the nanometer scale, agglutination plays an important role in immunological 
processes. Antibodies frequently have multiple sites for antigen binding which 
may result in aggregation and an amplified immune response. This process 
functions effectively as a type of signal amplification in which the local 
concentrations of binding reactants are dramatically increased. 
The above examples of agglutination are facilitated by the polyvalent nature of 
the reactants. Polyvalency is an exquisite way to increase the effective strength of 
interactions among reactants, enabling aggregation-based assembly.[14] In 
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particular, polyclonal antibody-antigen binding relies on multiple binding sites 
of antibody interacting with antigen. However, polyvalency has not been 
explicitly utilized in nucleic acid-based assays, due to the fact that most DNA is 
linear or circular and hence is typically treated as monovalent probes or primers 
in conventional nucleic acid detection methods. 
In this Chapter, the concept of agglutination is extended from antibody-antigen 
interactions to nucleic acid hybridization, and the use of DNA hybridization for 
aggregation phenomenon is explored with possible applications in molecular 
diagnostics. DNA-based agglutination using microbeads has been previously 
demonstrated.[11], [12] Similarly, aggregation of DNA-capped gold 
nanoparticles was pioneered by Mirkin as a novel and ultrasensitive method for 
nucleic acid detection.[10] Various works have been published on the underlying 
theory and characterization of gold nanoparticles assembly using DNA as a 
linker.[13]  
In contrast to these works, our hybridization-driven aggregates are formed 
entirely from DNA without any additional materials (no beads or nanoparticles). 
Importantly, this approach can be easily interfaced with multiple detection 
modalities, including gel electrophoresis, optical (both bright field and 
fluorescence) microscopy, atomic force microscopy, dynamic light scattering 
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(DLS), fluorescent correlation spectroscopy (FCS), and electrochemical detection. 
Thus, this approach suggests a flexible platform technology that can be easily 
modified and further integrated in multiple formats depending on the desired 
real-world applications. 
The free energy of a DNA duplex can be estimated, according to its sequence, 
using the nearest neighbor model.[15] However, hybridization-driven 
aggregation is theoretically more complex and polyvalent binding behavior 
becomes difficult to model. Thus, in this work, we relied heavily on empirical 
testing to determine the characteristics of hybridization-driven aggregation. 
 
4.3 Hybridization-driven aggregation 
To overcome the limitations of current nucleic acid detection methodologies and 
work toward POC diagnostics, we have developed a nucleic acid-based detection 
platform that enables signal amplification via hybridization instead of via an 
enzymatic reaction. This concept was based on the target-driven detection 
method using ABC monomers, previously developed in our laboratory.[16] In 
contrast to existing branched DNA (bDNA) assays,[17], [18] our hybridization-
driven aggregation approach does not use surface-based hybridization or 
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enzyme labeling, both of which introduce additional procedural complexity, 
which is extremely undesirable for point-of-care applications. 
Our approach, as shown in Figure 4.1, involves the use of cross-linked 
amplification (CLAMP) structures for target-driven hybridization and 
aggregation. Each CLAMP structure is designed to contain a simple Y-shaped 
branched DNA core with single-stranded capture probes for recognition of a 
specific pathogen biomarker (nucleic acid). The recognition step simply involves 
mixing our CLAMP structures with a patient sample containing the target 
biomarker. This capture probe can then bind to specific nucleic acids (ssDNA or 
mRNA) through the design of complementary sequences for base-pairing. After 
mixing, the DNA monomers and target biomarkers in the patient sample rapidly 
recognize and bind within several minutes due to the fast kinetics of solution-
phase hybridization, and the CLAMP structures become linked together, self-
assembling in the presence of a specific pathogen DNA target. However, if the 
target pathogen DNA is absent, there is nothing to link the DNA monomers 
together, and aggregation does not occur. 
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 Figure 4.1: Scheme illustrating the hybridization-based DNA aggregation 
approach. In the presence of target, the branched DNA probes bind to multiple 
target copies while each target binds to multiple branched DNA probes. The 
resulting hybridization leads to aggregation. In the absence of target, no 
hybridization occurs and no aggregation takes place. A novel electrochemical 
sensor is used to distinguish between the relatively large aggregates and much 
smaller branched DNA structures which remain dissociated in solution. 
 
The effect of aggregation is an increase in local concentration, which can be 
considered as an amplification of signal. After the amplification step, we carry 
out a detection step to distinguish between the large aggregates and the smaller 
DNA monomers. In this stage of our assay, we can carry out detection via several 
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different methods, as previously mentioned, including gel electrophoresis, 
dynamic light scattering, electrochemical detection, and microscopy. 
 
4.4 Target selection and sequence design 
As a prototypical target pathogen, we selected human immunodeficiency virus 
(HIV) due to its importance in the developing world. We selected a target region 
within a conserved region of the HIV genome based on the NCBI database and 
literature.[19] The sequence we selected is also used within a hybridization probe 
for an FDA-approved RT-PCR assay. We designed complementary DNA capture 
probes to be partially complementary to this target region and we appended 
these capture probe sequences to our Y-shaped DNA structural sequences. 
Sequences used in this experiment are shown in Table 4.2. 
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HIV target TGTTAAAAGAGACCATCAATGAGGA
AGCTGCAGAATGGGATAGATTGCAT 
50 bases 
Probe 3’ ATCCCATTCTGCAGC   15 bases, Tm 48.7oC 
Probe 5’ TTCCTCATTGATGGTCTCTTTT 18 bases, Tm 48.5oC 
Table 4.2: Set of HIV target and probe sequences. Binds to a region of the HIV-1 
gag gene sequence, which is highly conserved[19]. According to BLAST, the 
target sequence used here is a perfect match to nearly 1000 known HIV-1 
sequences (e.g. GenBank JF760180.1). 
 
4.5 Proof-of-concept using gel electrophoresis 
Gel electrophoresis was used to demonstrate the basic operation of our assay, as 
shown in Figure 4.2. The target sequence is synthetic DNA corresponding to HIV 
sequence. The target alone ran at a relatively low position in the agarose gel 
(arrow), while the CLAMP structures ran slightly higher. Upon mixing target 
and CLAMP structures together, we observed a smear corresponding to a wide 
distribution of product aggregate sizes. However, in the presence of an unrelated 
target, there was no interaction between the CLAMPS and the target. Thus, our 
hybridization-driven aggregation response was specific to the intended target 
sequence. 
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 Figure 4.2: Gel electrophoresis showing proof of principle for our aggregation-
based assay. Lane 1: 100 base-pair double-stranded DNA ladder. Lane 2: Target 
sequence (synthetic single-stranded DNA 50-mer with conserved sequence from 
HIV). Lane 3: Mixture of two different branched DNA probes. Lane 4: Mixture of 
branched DNA probes with an unrelated DNA target (conserved sequence from 
Influenza A).  
 
4.5 Study of assay robustness 
The above results were obtained by carrying out the aggregation assay under 
well-controlled laboratory conditions. These conditions are summarized in Table 
4.3. Briefly, a sample containing the target sequence was added to a solution 
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containing our CLAMP structures and mixed gently by pipetting. The mixture 
was incubated at room temperature for one hour without further treatment or 
handling. The room temperature was controlled at 20 °C. The solutions were 
buffered against acid/alkaline conditions and maintained at pH 7.4. The solutions 
were prepared using ultrapure autoclaved water. After the one hour incubation, 
samples were immediately characterized using gel electrophoresis. In summary, 
these typical laboratory conditions were not necessarily representative of harsh 
uncontrolled conditions that may be experienced at the point of care in a 
resource-limited setting. Thus, we carried out additional sets of experiments to 
verify the robustness of our process in the context of various disturbances to our 
established experimental procedure as well as the presence of various 
contaminating interferences within the test samples. 
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Ideal (non-POC) conditions for hybridization based aggregation process 
Reaction conditions Simple mixing, no shaking 
Temperature 20 °C 
Hybridization duration 1 hr 
Water quality Ultrapure autoclaved water 
Acidity/alkalinity Buffered at pH 7.4 
Table 4.3: Summary of conditions used for the “best case” aggregation 
experiment, prior to testing with more challenging sample conditions as 
discussed below. 
 
We sought to confirm the performance of our system across a range of non-ideal 
procedural conditions. First, we varied the operating temperature for the 
hybridization step, as shown in Figure 4.3. We observed that aggregation 
resulted in a consistent response even when the hybridization step was carried 
out above the theoretical melting temperature of the probe (approximately 55 
°C). We speculate that this consistent behavior was due to enhanced binding 
offered by the polyvalent probes, which may have resulted in increased local 
concentrations of reactants and thus raising the effective melting temperature. 
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Secondly, we varied the duration of the hybridization steps. We observed the 
aggregation occurred for all the time spans tested, surprisingly even within five 
minutes. This extremely rapid hybridization could be partially explained by the 
high concentration of reactants in the sample (1 µM for each species of CLAMP 
structure), and lower concentrations were expected to result in slower kinetics 
with a yield of aggregate product that was highly dependent on the duration of 
hybridization. We also tested a range of annealing programs but did not observe 
any difference in the aggregation behavior for these samples. 
 
Figure 4.3: Gel electrophoresis to show effect of varying duration and 
temperature for the aggregation process. Results indicate aggregation occurs 
under both conditions. 
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To explore the possibility of using impure water samples as diluent for our assay, 
we obtained water from a variety of unconventional sources (including 
unpurified tap water, river water, and rain water) and carried out our assay 
within these samples. For all water conditions tested, we did not observe any 
change in the assay performance, though the presence of particulates in the 
water slightly affected the resulting smear in the gel electrophoresis image. We 
also adjusted the pH in our samples over a very broad range, from pH 3 to pH 
11, and observed aggregation in all samples except for the pH 3 sample, in which 
the DNA appeared to be degraded (the DNA was likely depurinated under this 
extreme condition, some references give pH 4 as the threshold below which 
DNA is typically degraded). 
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 Figure 4.4: Gel electrophoresis to demonstrate the effect of varying water quality 
and pH on the sample results. Despite the impure water quality and varying pH, 
the aggregation process remained unaffected. For the pH of 3, DNA samples 
were degraded, so this condition is unsuitable for our assay. 
 
In addition to testing procedural disturbances, we also considered the potential 
for sample contamination. This was important because the sample preparation 
process might be less clean at the point of care, and thus POC samples may tend 
to contain more contaminants than samples prepared in a conventional 
laboratory setting. We tested for this possibility by preparing samples spiked 
with various common contaminants, as shown in Figures 4.5 and 4.6. In 
particular, we spiked samples with various concentrations of red blood cells, 
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human serum, sodium chloride, and Hank’s buffered saline solution. Again we 
found that the aggregation process was extremely reliable, such that none of the 
contaminants interfered with our assay.  
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 Figure 4.5: Gel electrophoresis demonstrating aggregation process in the 
presence of sample contamination. Background DNA does not interfere with the 
aggregation process. Red blood cells result in some disruption of the 
electrophoresis running pattern, possibly due to aggregation of blood cells in the 
well, but otherwise the aggregation process is unaffected. Human serum seems 
to result in some increased smearing of gel electrophoresis bands, but 
aggregation product is still clearly visible. 
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 Figure 4.6: Gel electrophoresis showing aggregation process under different 
sodium chloride and Hank’s Balanced Salt Solution (HBSS) concentrations. 
Limited aggregation was observed for 15 and 10 mM NaCl concentrations, since 
the sodium cation concentration was too low to facilitate hybridization. 
 
Overall, through the aforementioned experiments, the aggregation process 
utilized in our assay was shown to be very robust over a fairly broad range of 
conditions. This unexpected result seems reasonable when we consider that 
hybridization itself is a very robust process, so our aggregation process based on 
hybridization was naturally robust as well.  
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4.7 Electrochemical detection 
To achieve more sensitive detection with practical implications for POC testing, 
we also tested the detection of hybridization-driven aggregates using an 
electrochemical sensor.[20], [21] [20], [21] The sensor was capable of 
discriminating between aggregates and Y-shaped DNA based on dielectric 
(impedance) spectroscopy. This sensor has excellent advantages for POC 
detection, as shown in Table 4.4: it has a small compact size (important for 
portability), monolithic integration (no moving or fragile components), low 
power requirement (the CMOS-based platform is extremely efficient, potentially 
requiring only a small battery), low cost using established manufacturing 
processes, and consistent with existing CMOS standards enabling future 
integration with existing electronic devices.  
  
113 
 
 Small size 
Millimeter to centimeter scale, lightweight and 
portable 
Stability 
Monolithic architecture, robust with no fragile or 
moving components 
Low power 
requirement 
CMOS consumes power only to switch states 
Cost efficient 
manufacturing 
Highly scalable foundry-based production 
Integration with 
components 
Existing standards guarantees simple interfacing 
with additional CMOS features 
Table 4.4: Brief list of advantages for using CMOS electrochemical sensor for 
point-of-care detection, relative to other candidate sensor technologies such as 
optical or mechanical sensors. 
 
The device works similar to a traditional ion-sensitive field effect transistor 
(ISFET), in which current flows from source to drain and is modulated by a 
sensing gate. In a modification of the traditional ISFET design, Kan laboratory 
introduced an additional control gate, which allows the inputs to be weighted or 
thresholded. This control gate functions as a parallel input, with the inputs from 
the control gate and sensing gate both affecting the modulation of channel 
current. The ability to utilize weighted inputs allows the device to exhibit 
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neuron-like behavior, so this device is termed chemoreceptive neuron MOS, or 
CνMOS. 
 
 
Figure 4.7: Basic principles of operation of ISFET and CνMOS in the mode of 
impedance (dielectric) spectroscopy. 
 
This sensor was utilized for dielectric spectroscopy, which is a mode of 
measurement for characterizing the behavior of a medium in response to an 
alternating current. A probe was brought into contact with the sample and an AC 
field was applied. The input signal and output signal are measured and the 
relative changes to magnitude and phase give a unique signature that is related 
to the impedance characteristics of the sample. Using this approach, 
INPUT
OUTPUT
Chemical 
solution
Reference 
electrode
Source Drain
Channel
Gate oxide
Bulk
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hybridization-driven aggregates show a unique response compared to YDNA 
alone. 
We tested the CMOS electrochemical sensor in impedance spectroscopy mode 
with a set of samples with a range of target concentrations, and we sought to 
determine an estimate of the sensitivity limit for our system. Using this 
electrochemical detection approach, we determined the limit of detection for 
hybridization-driven aggregation was between 100 femtomolar and 50 
picomolar. 
 
4.8 Gold nanoparticles for enhanced sensitivity 
Encouraged by our preliminary tests of limit of detection, we sought to boost the 
sensitivity even further. In order to further exaggerate the difference between 
samples containing DNA aggregates (test positive results), and those containing 
no aggregates (test negative results), we determined it would be helpful to add 
gold nanoparticles as an additional component of the assay. Gold nanoparticles 
are a popular choice for working with DNA, and we had prior experience with 
DNA-capped gold nanoparticles in our group. Utilizing thiol-modified 
oligonucleotides, we prepared gold nanoparticles coated with capture probes 
that could recognize specific regions within the intended target sequences. 
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Figure 4.8: Scheme illustrating the use of gold nanoparticles with branched 
polyvalent probes for enzyme-free nucleic acid detection. The addition of gold 
nanoparticles to our assay was expected to result in enhanced sensitivity and 
reduced limit of detection. 
 
For our first trial, we used bright field microscopy for testing our aggregation 
with DNA-capped gold nanoparticles. We observed obvious aggregation within 
the samples containing gold nanoparticles with DNA probes and target 
sequences. We further prepared a “scaled-up” version of this reaction and we 
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could clearly see the aggregates precipitate out of the solution over a duration of 
a few hours. We could also observe aggregation over shorter time scales using 
dynamic light scattering (DLS). These preliminary results demonstrated that the 
addition to gold nanoparticles did not interfere with our aggregation process and 
could potentially enable new modes for detection. 
 
 
Figure 4.9: Optical microscopy of gold nanoparticle aggregates. Target-driven 
hybridization results in obvious aggregation of gold nanoparticles into dark 
clusters. 
 
 
118 
 
 Figure 4.10: Naked eye detection of gold nanoparticle aggregates. Aggregation 
results in precipitation, which removes color from the solution. 
 
Encouraged by these results, we further prepared samples for testing with the 
electrochemical sensor. We prepared a range of target concentrations, and 
carried out impedance spectroscopy measurements as previously described 
above. We found that the gold nanoparticles did in fact improve the sensitivity, 
allowing for highly sensitive results even at low target concentrations. We 
observed a response down to 100 femtomolar, which is almost hundred-fold 
improvement over our previous limit of detection, and superior to many 
established diagnostic methods. For example, the popular method enzyme-
linked immunosorbent assay (ELISA) has a limit of detection of approximately 10 
picomolar; furthermore, ELISA uses enzymes whereas our assay is enzyme-free 
and hence much more suitable for POC detection.  
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4.9 Conclusion and outlook 
In conclusion, we demonstrated a streamlined aggregation process that is 
suitable for minimally complex detection. Importantly, this process is entirely 
enzyme-free, avoiding the limitations associated with using enzymes at the 
point-of-care. We have demonstrated this process is highly specific and robust 
against both procedural disturbances and sample contamination, which is of 
critical importance for establishing feasibility to use our assay at the point-of-
care. We further demonstrated the detection of our aggregates using a POC-
friendly electrochemical sensor. We used this system in a preliminary feasibility 
study to uniquely identify a target DNA sequence from HIV down to 50 
picomolar concentration. By implementing gold nanoparticles into our assay, we 
further increased our sensitivity and reduced our detection limit down to 100 
femtomolar concentration. 
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CHAPTER 5 
CONCLUSION AND OUTLOOK 
 
One of the central goals of nanotechnology is the precise control and 
manipulation of matter on the nanometer scale. As the state of the art for design 
and synthesis of DNA nanostructures continues to advance, this goal is 
becoming increasingly easy to realize through DNA nanotechnology. For 
example, the use of DNA origami and molecular canvas approaches, as 
demonstrated in recent publications, have enabled unprecedented feats of 
nanometer-scale engineering. However, the practical significance of DNA 
nanostructures has been slow to materialize, and a real-world demonstration of 
DNA nanostructures as utilized for practical applications would be extremely 
valuable for motivating further advancement in this field. 
One of the most direct and important applications for DNA nanostructures is in 
the area of molecular diagnostics. Nucleic acids obviously play a critical role in 
biological processes, but historically and traditionally have not played a leading 
role in the diagnostic clinical laboratory. Instead, cell culture and immunological-
based tests have dominated due to their earlier development and precedence. For 
example, the first cell culture experiments were carried out in the 1800s, and cell 
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culture became a common laboratory technique in the mid-1900s,[1]. Practical 
diagnostic methods utilizing nucleic acids were not fully developed and adopted 
until recent decades (PCR was not developed until 1983)[2]. As the utility of 
nucleic acids as biomarkers is increasingly recognized, and as molecular biology 
and sequencing technologies continue to advance, molecular diagnostics are 
steadily growing in importance for both research and clinical applications. 
Molecular diagnostic techniques, including detection, expression profiling, and 
sequencing, are revolutionizing the standard of care for clinical prognostics and 
diagnostics. 
Virtually all techniques in the area of molecular diagnostics techniques must 
make use of DNA as primers and/or probes. Even simple variations on the 
standard DNA primers and probes has led to a vast assortment of technologies, 
including molecular beacons, scorpion probes, bDNA assays, etc. Thus, the full 
range of possibilities offered by DNA nanotechnology offers incredible promise 
for the development of new and disruptive diagnostic technologies. The unique 
advantages that arise from DNA nanostructures, such as multifunctionality and 
controllability, could potentially have great benefits for molecular diagnostic 
techniques. However, the potential of branched DNA nanostructures has not 
been fully explored and utilized in these applications. This is a great opportunity 
for fundamental and applied research on DNA nanotechnology to integrate 
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DNA nanostructures into molecular diagnostic applications, before current 
practices become widely-adopted and standardized.  
Chapter 2 described an approach to overcome current limitations or concerns 
about the stability of DNA nanostructures. Simple photo-cross-linking treatment 
using psoralen, an inexpensive and naturally-occurring chemical, can generate 
DNA nanostructures with thermostable property. The enhanced stability of these 
structures was confirmed under various denaturing conditions, and it was 
shown that this method was general and could be applied to any branched DNA 
nanostructure design. The thermostable structures were then utilized in PCR (as 
“modular primers”) and the resulting PCR products showed that these “modular 
primers” resulted in various PCR products that were impossible to achieve in 
conventional PCR with linear primers. For example, the use of fluorophore-
labeled modular primers could allow the “DNA nanobarcodes” concept to work 
with enhanced sensitivity (theoretically improving the sensitivity limit to that of 
PCR), using multiplexed PCR to carry out simultaneous amplification and 
multiplexed labeling of products. Furthermore, modular primers containing 
multiple linear primers on a single branched structure enabled the production of 
multi-armed branched PCR products which could be used for the delivery of 
controlled ratio of genes. In addition, a DNA hydrogel produced through PCR of 
multiple branched primers was demonstrated, with applications for cell free 
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protein expression. In summary, a varied assortment of novel PCR products 
were produced from the same straightforward approach, demonstrating the 
power and versatility of applying DNA nanostructures to an established 
molecular biology technique. The focus of this work was on PCR, but the 
enhanced stability of thermostable DNA nanostructures could be beneficial for 
many other important applications that involve potentially denaturing 
conditions. 
Chapter 4 described empirical studies of a general system that is fundamental for 
DNA nanostructures: hybridization-driven aggregation. Whereas many assays 
utilize immunologically-based agglutination, nucleic acid-based agglutination is 
rarely considered as a feasible approach for detection. Our approach utilized 
branched DNA nanostructures with multiple capture probes on each single 
structure. As a result, each probe could bind to multiple targets and each target 
could bind to multiple probes. Our experiments indicated that individual DNA 
hybridization events could result in aggregation and lead to very high local 
concentration of DNA. This response was shown to be specific, occurring only in 
the presence of a specific target DNA sequence in conjunction with probes that 
were designed to be complementary. We further demonstrated that this response 
was robust and could be carried out under a broad range of reaction conditions, 
both by varying procedural parameters for the aggregation process and by 
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testing contaminated samples spiked with common interferents. We utilized an 
electrochemical sensor for the detection of the resulting aggregates, 
demonstrating a potentially viable strategy for point of care detection in resource 
limited settings. To demonstrate the feasibility of POC diagnostics using this 
platform, we utilized an electrochemical sensor for measurement of the resulting 
hybridization-driven aggregates, achieving a detection limit down to 50 
picomolar. This entire system is compatible with POC diagnostics and could be 
extremely valuable for resource limiting settings such as the developing world. 
In addition to detection, this work was useful as a fundamental study of DNA-
based self-assembly and hybridization-driven polymerization. 
The works described in this dissertation sought to demonstrate the feasibility 
and advantages of DNA nanostructures in molecular diagnostics, with the aim to 
strengthen claims of practical significance for DNA nanotechnology. Future 
work in this area could aim to achieve real-world implementation and focus on 
utilizing the platform technologies describe here in conjunction with more 
realistic sample matrices and environmental conditions. With further 
development, the incorporation of DNA nanostructures into existing and novel 
strategies for molecular diagnostics will ultimately lead to advancements in 
diagnostics and improved clinical outcomes. 
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